Publications

Publications published since 2005 or in press from OUS - Department of Oncology

1169 publications found (only first 1000 shown)

Publications in press

1. Abbas N, Heyerdahl H, Bruland OS, Brevik EM, Dahle J
   Comparing high LET 227Th- and low LET 177Lu-trastuzumab in mice with HER-2 Positive SKBR-3 Xenografts
   Curr Radiopharm (in press)
   PubMed 23551110
2. Amdal CD, Jacobsen AB, Sandstad B, Warloe T, Bjordal K
   Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial
   Radiother Oncol (in press)
   PubMed 23647761
3. Andreassen KE, Kristiansen W, Karlsson R, Aschim EL, Dahl O, Fosså SD, Adami HO, Wiklund F, Haugen TB, Grotmol T
   Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor
   Hum Reprod (in press)
   PubMed 23639623
4. Brandberg Y, Johansson H, Aamdal S, Bastholt L, Hernberg M, Stierner U, von der Maase H, Hansson J, for the Nordic Melanoma Cooperative Group
   Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma
   Acta Oncol (in press)
   PubMed 23621752
5. Brenne E, Loge JH, Kaasa S, Heitzer E, Knudsen AK, Wasteson E
   Depressed patients with incurable cancer: Which depressive symptoms do they experience?
   Palliat Support Care, 1-11 (in press)
   PubMed 23388067
6. Brustugun OT, Helland A
   Rapid reduction in the incidence of cancer of unknown primary. A population-based study
   Acta Oncol (in press)
   PubMed 23550957
7. Chung CC, Kanetsky PA, Wang Z, Hildebrandt MA, Koster R, Skotheim RI, Kratz CP, Turnbull C, Cortessis VK, Bakken AC, Bishop DT, Cook MB, Erickson RL, Fosså SD, Jacobs KB, Korde LA, Kraggerud SM, Lothe RA, Loud JT, Rahman N, Skinner EC, Thomas DC, Wu X, Yeager M, Schumacher FR et al.
   Meta-analysis identifies four new loci associated with testicular germ cell tumor
   Nat Genet (in press)
   PubMed 23666239
8. Edvardsen H, Landmark-Høyvik H, Reinertsen KV, Zhao X, Grenaker-Alnæs GI, Nebdal D, Syvänen AC, Rødningen O, Alsner J, Overgaard J, Borresen-Dale AL, Fosså SD, Kristensen VN
   SNP in TXNRD2 Associated with Radiation-Induced Fibrosis: A Study of Genetic Variation in Reactive Oxygen Species Metabolism and Signaling
   Int J Radiat Oncol Biol Phys (in press)
   PubMed 23597419
9. Eide N, Hoifødt HK, Nesland JM, Faye RS, Qvale GA, Faber RT, Jebsen P, Kvalheim G, Fodstad O
   Disseminated tumour cells in bone marrow of patients with uveal melanoma
   Acta Ophthalmol (in press)
   PubMed 22632270
10. Fosså A, Røsok BI, Kazaryan AM, Holte HJ, Brennhovd B, Westerheim O, Marangos IP, Edwin B
    Laparoscopic versus open surgery in stage I-III adrenocortical carcinoma - a retrospective comparison of 32 patients
    Acta Oncol (in press)
    PubMed 23398621
11. Grytli HH, Fagerland MW, Fosså SD, Taskén KA
    Association Between Use of ?-Blockers and Prostate Cancer-Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease
    Eur Urol (in press)
    PubMed 23351721
12. Grytli HH, Fagerland MW, Fosså SD, Taskén KA
    Reply to Chris R. Cardwell, Samy Suissa and Liam J. Murray's Letter to the Editor re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association Between Use of ?-Blockers and Prostate Cancer-Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007
    Eur Urol (in press)
    PubMed 23602404
13. Heyerdahl H, Abbas N, Sponheim K, Mollatt C, Bruland O, Dahle J
    Targeted Alpha Therapy with 227Th-trastuzumab of Intraperitoneal Ovarian Cancer in Nude Mice
    Curr Radiopharm (in press)
    PubMed 23551111
14. Hofoss D, Dahl E, Ivar Elstad J, Cvancarova M
    Selection and mortality: a ten-year follow-up of income decile mortality in Norway
    Eur J Public Health (in press)
    PubMed 23002239
15. Hofsø K, Rustøen T, Cooper BA, Bjordal K, Miaskowski C
    Changes Over Time in Occurrence, Severity, and Distress of Common Symptoms During and After Radiation Therapy for Breast Cancer
    J Pain Symptom Manage (in press)
    PubMed 23026547
16. Holm HV, Fosså SD, Hedlund H, Dahl AA
    Study of generic quality of life in patients operated on for post-prostatectomy incontinence
    Int J Urol (in press)
    PubMed 23418855
17. Iversen PO, Negaard H, Ostenstad B, Sandset PM, Kolset SO
    Evidence for long term hypercoagulopathy, but normalization of markers of extracellular matrix turnover, in patients with non-Hodgkin lymphoma
    Leuk Lymphoma (in press)
    PubMed 23656198
18. Karlsson R, Andreassen KE, Kristiansen W, Aschim EL, Bremnes RM, Dahl O, Fosså SD, Klepp O, Langberg CW, Solberg A, Tretli S, Magnusson PK, Adami HO, Haugen TB, Grotmol T, Wiklund F
    Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4
    Hum Mol Genet (in press)
    PubMed 23640991
19. Lagunova Z, Porojnicu AC, Aksnes L, Holick MF, Iani V, Bruland OS, Moan J
    Effect of vitamin D supplementation and ultraviolet B exposure on serum 25-hydroxyvitamin D concentrations in healthy volunteers: a randomized, crossover clinical trial
    Br J Dermatol (in press)
    PubMed 23551243
20. Lilleby W, Stensvold A, Dahl AA
    Intensity-modulated radiotherapy to the pelvis and androgen deprivation in men with locally advanced prostate cancer: A study of adverse effects and their relation to quality of life
    Prostate (in press)
    PubMed 23532709
21. Liu Y, Wu X, Li X, Kvalheim G, Axcrona U, Axcrona K, Suo Z
    Blocking mtDNA Replication Upregulates the Expression of Stemness-related Genes in Prostate Cancer Cell Lines
    Ultrastruct Pathol (in press)
    PubMed 23634795
22. Moestue SA, Dam CG, Gorad SS, Kristian A, Bofin A, Mælandsmo GM, Engebråten O, Gribbestad IS, Bjørkøy G
    Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
    Breast Cancer Res, 15 (1), R16 (in press)
    PubMed 23448424
23. Mustjoki S, Richter J, Barbany G, Ehrencrona H, Fioretos T, Gedde-Dahl T, Gjertsen BT, Hovland R, Hernesniemi S, Josefsen D, Koskenvesa P, Dybedal I, Markevärn B, Olofsson T, Olsson-Strömberg U, Rapakko K, Thunberg S, Stenke L, Simonsson B, Porkka K, Hjorth-Hansen H
    Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
    Leukemia (in press)
    PubMed 23328954
24. Nekolaichuk CL, Fainsinger RL, Aass N, Hjermstad MJ, Knudsen AK, Klepstad P, Currow DC, Kaasa For The European Palliative Care Research Collaborative Epcrc S
    The Edmonton Classification System for Cancer Pain: Comparison of Pain Classification Features and Pain Intensity Across Diverse Palliative Care Settings in Eight Countries
    J Palliat Med (in press)
    PubMed 23614710
25. Paulsen O, Aass N, Kaasa S, Dale O
    Do Corticosteroids Provide Analgesic Effects in Cancer Patients? A Systematic Literature Review
    J Pain Symptom Manage (in press)
    PubMed 23149084
26. Rayment C, Hjermstad MJ, Aass N, Kaasa S, Caraceni A, Strasser F, Heitzer E, Fainsinger R, Bennett MI, On behalf of the European Palliative Care Research Collaborative (EPCRC)
    Neuropathic cancer pain: Prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study
    Palliat Med (in press)
    PubMed 23175513
27. Rusten E, Rødal J, Revheim ME, Skretting A, Bruland OS, Malinen E
    Quantitative dynamic (18)FDG-PET and tracer kinetic analysis of soft tissue sarcomas
    Acta Oncol (in press)
    PubMed 23198721
28. Rustøen T, Valeberg BT, Kolstad E, Wist E, Paul S, Miaskowski C
    A Randomized Clinical Trial of the Efficacy of a Self-care Intervention to Improve Cancer Pain Management
    Cancer Nurs (in press)
    PubMed 23666269
29. Schumacher FR, Wang Z, Skotheim RI, Koster R, Chung CC, Hildebrandt MA, Kratz CP, Bakken AC, Timothy Bishop D, Cook MB, Erickson RL, Fosså SD, Greene MH, Jacobs KB, Kanetsky PA, Kolonel LN, Loud JT, Korde LA, Le Marchand L, Pablo Lewinger J, Lothe RA, Pike MC, Rahman N, Rubertone MV, Schwartz SM et al.
    Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23
    Hum Mol Genet (in press)
    PubMed 23462292
30. Sioud M, Sæbøe-Larssen S, Hetland TE, Kærn J, Mobergslien A, Kvalheim G
    Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients
    Int J Oncol (in press)
    PubMed 23620105
31. Skarstein S, Rosvold EO, Helseth S, Kvarme LG, Holager T, Småstuen MC, Lagerløv P
    High-frequency use of over-the-counter analgesics among adolescents: reflections of an emerging difficult life, a cross-sectional study
    Scand J Caring Sci (in press)
    PubMed 23517110
32. Steindal SA, Ranhoff AH, Bredal IS, Sørbye LW, Lerdal A
    Last three days of life in the hospital: a comparison of symptoms, signs and treatments in the young old and the oldest old patients using the Resident Assessment Instrument for Palliative Care
    Int J Older People Nurs (in press)
    PubMed 22329702
33. Stensvold A, Dahl AA, Brennhovd B, Småstuen MC, Fosså SD, Lilleby W, Steinsvik A, Axcrona K, Smeland S
    Bother problems in prostate cancer patients after curative treatment
    Urol Oncol (in press)
    PubMed 22341412
34. Torp S, Grimsmo A, Hagen S, Duran A, Gudbergsson SB
    Work engagement: a practical measure for workplace health promotion?
    Health Promot Int (in press)
    PubMed 22692482
35. Valeberg BT, Kolstad E, Småstuen MC, Miaskowski C, Rustøen T
    The PRO-SELF Pain Control Program Improves Family Caregivers' Knowledge of Cancer Pain Management
    Cancer Nurs (in press)
    PubMed 23154516
36. Wahlin BE, Sundström C, Sander B, Christensson B, Jeppsson-Ahlberg A, Hjalmarsson E, Holte H, Ostenstad B, Brown PD, Smeland EB, Kimby E
    Higher WHO grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy
    Leuk Lymphoma (in press)
    PubMed 23662992
37. Weberg M, Hjermstad MJ, Hilmarsen CW, Oldervoll L
    Inpatient cardiac rehabilitation and changes in self-reported health related quality of life - a pilot study
    Ann Phys Rehabil Med (in press)
    PubMed 23601857
38. Yri OE, Ekstrøm PO, Hilden V, Gaudernack G, Liestøl K, Smeland EB, Holte H
    Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab
    Leuk Lymphoma (in press)
    PubMed 23391141

Publications 2013

1. Amdal CD, Jacobsen AB, Guren MG, Bjordal K (2013)
   Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review
   Acta Oncol, 52 (4), 679-90
   PubMed 23190360
2. Aure MR, Steinfeld I, Baumbusch LO, Liestøl K, Lipson D, Nyberg S, Naume B, Sahlberg KK, Kristensen VN, Børresen-Dale AL, Lingjærde OC, Yakhini Z (2013)
   Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data
   PLoS One, 8 (1), e53014
   PubMed 23382830
3. Balducci L, Fossa SD (2013)
   Rehabilitation of older cancer patients
   Acta Oncol, 52 (2), 233-8
   PubMed 23320771
4. Barrett ES, Thune I, Lipson SF, Furberg AS, Ellison PT (2013)
   A factor analysis approach to examining relationships among ovarian steroid concentrations, gonadotrophin concentrations and menstrual cycle length characteristics in healthy, cycling women
   Hum Reprod, 28 (3), 801-11
   PubMed 23250924
5. Barrett ES, Tran V, Thurston S, Jasienska G, Furberg AS, Ellison PT, Thune I (2013)
   Marriage and motherhood are associated with lower testosterone concentrations in women
   Horm Behav, 63 (1), 72-9
   PubMed 23123222
6. Baumbusch LO, Helland Å, Wang Y, Liestøl K, Schaner ME, Holm R, Etemadmoghadam D, Alsop K, Brown P, Australian Ovarian Cancer Study Group, Mitchell G, Fereday S, DeFazio A, Bowtell DD, Kristensen GB, Lingjærde OC, Børresen-Dale AL (2013)
   High levels of genomic aberrations in serous ovarian cancers are associated with better survival
   PLoS One, 8 (1), e54356
   PubMed 23372714
7. Bentzen AG, Balteskard L, Wanderås EH, Frykholm G, Wilsgaard T, Dahl O, Guren MG (2013)
   Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors
   Acta Oncol, 52 (4), 736-44
   PubMed 23438358
8. Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, Cathomas R, Cavallin-Stahl E, Clarke NW, Claßen J, Cohn-Cedermark G, Dahl AA, Daugaard G, De Giorgi U, De Santis M, De Wit M, De Wit R, Dieckmann KP, Fenner M, Fizazi K, Flechon A, Fossa SD, Germá Lluch JR, Gietema JA, Gillessen S et al. (2013)
   Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
   Ann Oncol, 24 (4), 878-88
   PubMed 23152360
9. Borgan E, Lindholm EM, Moestue S, Mælandsmo GM, Lingjærde OC, Gribbestad IS, Børresen-Dale AL, Engebraaten O, Sørlie T (2013)
   Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts
   Mol Oncol, 7 (1), 130-42
   PubMed 23142657
10. Brelin S, Loge JH, Skurtveit S, Johannesen TB, Aass N, Ottesen S, Hjermstad MJ (2013)
    Antidepressants to cancer patients during the last year of life--a population-based study
    Psychooncology, 22 (3), 506-14
    PubMed 22392773
11. Bye A, Jordhøy MS, Skjegstad G, Ledsaak O, Iversen PO, Hjermstad MJ (2013)
    Symptoms in advanced pancreatic cancer are of importance for energy intake
    Support Care Cancer, 21 (1), 219-27
    PubMed 22684989
12. Børøsund E, Cvancarova M, Ekstedt M, Moore SM, Ruland CM (2013)
    How user characteristics affect use patterns in web-based illness management support for patients with breast and prostate cancer
    J Med Internet Res, 15 (3), e34
    PubMed 23454601
13. Cohen RB, Aamdal S, Nyakas M, Cavallin M, Green D, Learoyd M, Smith I, Kurzrock R (2013)
    A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies
    Eur J Cancer, 49 (7), 1521-9
    PubMed 23433846
14. Cvancarova M, Aagnes B, Fosså SD, Lambert PC, Møller B, Bray F (2013)
    Proportion cured models applied to 23 cancer sites in Norway
    Int J Cancer, 132 (7), 1700-10
    PubMed 22927104
15. Dahl AA, Olssøn I (2013)
    Unfavorable health conditions associated with high social anxiety in the elderly: a community-based study
    Nord J Psychiatry, 67 (1), 30-7
    PubMed 22429103
16. Dahle J, Repetto-Llamazares AH, Mollatt CS, Melhus KB, Bruland OS, Kolstad A, Larsen RH (2013)
    Evaluating antigen targeting and anti-tumor activity of a new anti-CD37 radioimmunoconjugate against non-Hodgkin's lymphoma
    Anticancer Res, 33 (1), 85-95
    PubMed 23267131
17. Dörffel W, Rühl U, Lüders H, Claviez A, Albrecht M, Bökkerink J, Holte H, Karlen J, Mann G, Marciniak H, Niggli F, Schmiegelow K, Schwarze EW, Pötter R, Wickmann L, Schellong G (2013)
    Treatment of Children and Adolescents With Hodgkin Lymphoma Without Radiotherapy for Patients in Complete Remission After Chemotherapy: Final Results of the Multinational Trial GPOH-HD95
    J Clin Oncol, 31 (12), 1562-8
    PubMed 23509321
18. Emaus A, Dieli-Conwright C, Xu X, Lacey JV, Ingles SA, Reynolds P, Bernstein L, Henderson KD (2013)
    Increased long-term recreational physical activity is associated with older age at natural menopause among heavy smokers: the California Teachers Study
    Menopause, 20 (3), 282-90
    PubMed 23435025
19. Grytli HH, Fagerland MW, Fosså SD, Taskén KA, Håheim LL (2013)
    Use of ?-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy
    Prostate, 73 (3), 250-60
    PubMed 22821802
20. Hagness M, Foss A, Line PD, Scholz T, Jørgensen PF, Fosby B, Boberg KM, Mathisen O, Gladhaug IP, Egge TS, Solberg S, Hausken J, Dueland S (2013)
    Liver transplantation for nonresectable liver metastases from colorectal cancer
    Ann Surg, 257 (5), 800-6
    PubMed 23360920
21. Hagtvedt T, Aaløkken TM, Smith HJ, Graff BA, Holte H, Kolbenstvedt A (2013)
    Enhancement characteristics of retroperitoneal lymphomatous lymph nodes
    Acta Radiol, 54 (3), 333-9
    PubMed 23446747
22. Hamre H, Zeller B, Kanellopoulos A, Ruud E, Fosså SD, Loge JH, Aukrust P, Halvorsen B, Mollnes TE, Kiserud CE (2013)
    Serum cytokines and chronic fatigue in adults surviving after childhood leukemia and lymphoma
    Brain Behav Immun, 30, 80-7
    PubMed 23333795
23. Holte H, Leppä S, Björkholm M, Fluge O, Jyrkkiö S, Delabie J, Sundström C, Karjalainen-Lindsberg ML, Erlanson M, Kolstad A, Fosså A, Ostenstad B, Löfvenberg E, Nordström M, Janes R, Pedersen LM, Anderson H, Jerkeman M, Eriksson M (2013)
    Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
    Ann Oncol, 24 (5), 1385-92
    PubMed 23247661
24. Hovind IL, Bredal IS, Dihle A (2013)
    Women's experience of acute and chronic pain following breast cancer surgery
    J Clin Nurs, 22 (7-8), 1044-52
    PubMed 23480500
25. Høivik ML, Moum B, Solberg IC, Henriksen M, Cvancarova M, Bernklev T, IBSEN Group (2013)
    Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study
    Gut, 62 (3), 368-75
    PubMed 22717453
26. Idland G, Rydwik E, Småstuen MC, Bergland A (2013)
    Predictors of mobility in community-dwelling women aged 85 and older
    Disabil Rehabil, 35 (11), 881-7
    PubMed 22931434
27. Johansen S, Tjessem KH, Fosså K, Bosse G, Danielsen T, Malinen E, Fosså SD (2013)
    Dose Distribution in the Heart and Cardiac Chambers Following 4-field Radiation Therapy of Breast Cancer: a Retrospective Study
    Breast Cancer (Auckl), 7, 41-9
    PubMed 23589693
28. Johnsen SJ, Brun JG, Gøransson LG, Småstuen MC, Johannesen TB, Haldorsen K, Harboe E, Jonsson R, Meyer PA, Omdal R (2013)
    Risk of Non-Hodgkin's Lymphoma in Primary Sjögren's Syndrome: A Population-Based Study
    Arthritis Care Res (Hoboken), 65 (5), 816-21
    PubMed 23139233
29. Jørgensen KK, Lindström L, Cvancarova M, Karlsen TH, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM (2013)
    Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease
    Clin Gastroenterol Hepatol, 11 (5), 517-23
    PubMed 23333218
30. Kanellopoulos A, Hamre HM, Dahl AA, Fosså SD, Ruud E (2013)
    Factors associated with poor quality of life in survivors of childhood acute lymphoblastic leukemia and lymphoma
    Pediatr Blood Cancer, 60 (5), 849-55
    PubMed 23335116
31. Kersten C, Cvancarova M, Mjåland S, Mjåland O (2013)
    Does in-house availability of multidisciplinary teams increase survival in upper gastrointestinal-cancer?
    World J Gastrointest Oncol, 5 (3), 60-7
    PubMed 23671732
32. Kolberg M, Høland M, Agesen TH, Brekke HR, Liestøl K, Hall KS, Mertens F, Picci P, Smeland S, Lothe RA (2013)
    Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
    Neuro Oncol, 15 (2), 135-47
    PubMed 23161774
33. Kyrdalen AE, Dahl AA, Hernes E, Småstuen MC, Fosså SD (2013)
    A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer
    BJU Int, 111 (2), 221-32
    PubMed 22672151
34. Larsson C, Kleppestø M, Rasmussen I, Salo R, Vardal J, Brandal P, Bjørnerud A (2013)
    Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results
    J Magn Reson Imaging, 37 (4), 818-29
    PubMed 23086710
35. Lilleby W, Stensvold A, Mills IG, Nesland JM (2013)
    Disseminated tumor cells and their prognostic significance in nonmetastatic prostate cancer patients
    Int J Cancer, 133 (1), 149-55
    PubMed 23280694
36. Lindberg MF, Grov EK, Gay CL, Rustøen T, Granheim TI, Amlie E, Lerdal A (2013)
    Pain characteristics and self-rated health after elective orthopaedic surgery - a cross-sectional survey
    J Clin Nurs, 22 (9-10), 1242-53
    PubMed 23551432
37. Laake I, Carlsen MH, Pedersen JI, Weiderpass E, Selmer R, Kirkhus B, Thune I, Veierød MB (2013)
    Intake of trans fatty acids from partially hydrogenated vegetable and fish oils and ruminant fat in relation to cancer risk
    Int J Cancer, 132 (6), 1389-403
    PubMed 22821174
38. Margolin AA, Bilal E, Huang E, Norman TC, Ottestad L, Mecham BH, Sauerwine B, Kellen MR, Mangravite LM, Furia MD, Vollan HK, Rueda OM, Guinney J, Deflaux NA, Hoff B, Schildwachter X, Russnes HG, Park D, Vang VO, Pirtle T, Youseff L, Citro C, Curtis C, Kristensen VN, Hellerstein J et al. (2013)
    Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer
    Sci Transl Med, 5 (181), 181re1
    PubMed 23596205
39. Michelsen TM, Dørum A, Cvancarova M, Liavaag AH, Dahl AA (2013)
    Association between hysterectomy with ovarian preservation and cardiovascular disease in a Norwegian population-based sample
    Gynecol Obstet Invest, 75 (1), 61-7
    PubMed 23220872
40. Myklebust JH, Irish JM, Brody J, Czerwinski DK, Houot R, Kohrt HE, Timmerman J, Said J, Green MR, Delabie J, Kolstad A, Alizadeh AA, Levy R (2013)
    High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells
    Blood, 121 (8), 1367-76
    PubMed 23297127
41. Naderi EH, Ugland HK, Diep PP, Josefsen D, Ruud E, Naderi S, Blomhoff HK (2013)
    Selective inhibition of cell death in malignant vs normal B-cell precursors: implications for cAMP in development and treatment of BCP-ALL
    Blood, 121 (10), 1805-13
    PubMed 23299313
42. Nilsson S, Franzén L, Parker C, Tyrrell C, Blom R, Tennvall J, Lennernäs B, Petersson U, Johannessen DC, Sokal M, Pigott K, O'Bryan-Tear CG, Thuresson M, Bolstad B, Bruland ØS (2013)
    Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases
    Clin Genitourin Cancer, 11 (1), 20-6
    PubMed 23021204
43. Nordby T, Hugenschmidt H, Fagerland MW, Ikdahl T, Buanes T, Labori KJ (2013)
    Follow-up after curative surgery for pancreatic ductal adenocarcinoma: Asymptomatic recurrence is associated with improved survival
    Eur J Surg Oncol, 39 (6), 559-66
    PubMed 23498362
44. Nordby T, Ikdahl T, Bowitz Lothe IM, Fagerland MW, Heiberg T, Hauge T, Labori KJ, Buanes T (2013)
    Improved survival and quality of life in patients undergoing R1 pancreatic resection compared to patients with locally advanced unresectable pancreatic adenocarcinoma
    Pancreatology, 13 (2), 180-5
    PubMed 23561977
45. Nordby T, Ikdahl T, Lothe IM, Anonsen K, Hauge T, Edwin B, Line PD, Labori KJ, Buanes T (2013)
    Opportunities of improvement in the management of pancreatic and periampullary tumors
    Scand J Gastroenterol, 48 (5), 617-25
    PubMed 23597153
46. Nordgård O, Singh G, Solberg S, Jørgensen L, Halvorsen AR, Smaaland R, Brustugun OT, Helland A (2013)
    Novel molecular tumor cell markers in regional lymph nodes and blood samples from patients undergoing surgery for non-small cell lung cancer
    PLoS One, 8 (5), e62153
    PubMed 23671585
47. Ohnstad HO, Castro R, Sun J, Heintz KM, Vassilev LT, Bjerkehagen B, Kresse SH, Meza-Zepeda LA, Myklebost O (2013)
    Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma
    Cancer, 119 (5), 1013-22
    PubMed 23165797
48. Olsen K, Danielsen K, Wilsgaard T, Sangvik M, Sollid JU, Thune I, Eggen AE, Simonsen GS, Furberg AS (2013)
    Obesity and Staphylococcus aureus Nasal Colonization among Women and Men in a General Population
    PLoS One, 8 (5), e63716
    PubMed 23667661
49. Olsen K, Sangvik M, Simonsen GS, Sollid JU, Sundsfjord A, Thune I, Furberg AS (2013)
    Prevalence and population structure of Staphylococcus aureus nasal carriage in healthcare workers in a general population. The Tromsø Staph and Skin Study
    Epidemiol Infect, 141 (1), 143-52
    PubMed 22440487
50. Pomianowska E, Westgaard A, Mathisen Ø, Clausen OP, Gladhaug IP (2013)
    Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas
    Ann Surg Oncol, 20 (1), 233-41
    PubMed 22893118
51. Radu C, Norrlid O, Brændengen M, Hansson K, Isacsson U, Glimelius B (2013)
    Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients
    Acta Oncol, 52 (3), 528-37
    PubMed 23113591
52. Reidunsdatter RJ, Albrektsen G, Hjermstad MJ, Rannestad T, Oldervoll LM, Lundgren S (2013)
    One-year course of fatigue after post-operative radiotherapy in Norwegian breast cancer patients--comparison to general population
    Acta Oncol, 52 (2), 239-48
    PubMed 23210971
53. Revheim ME, Kristian A, Malinen E, Bruland ØS, Berner JM, Holm R, Joensuu H, Seierstad T (2013)
    Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H
    Acta Oncol, 52 (4), 776-82
    PubMed 23480638
54. Røe K, Bratland A, Vlatkovic L, Ragnum HB, Saelen MG, Olsen DR, Marignol L, Ree AH (2013)
    Hypoxic Tumor Kinase Signaling Mediated by STAT5A in Development of Castration-Resistant Prostate Cancer
    PLoS One, 8 (5), e63723
    PubMed 23675504
55. Sartor O, Hoskin P, Bruland OS (2013)
    Targeted radio-nuclide therapy of skeletal metastases
    Cancer Treat Rev, 39 (1), 18-26
    PubMed 22534284
56. Schou Bredal I, Kåresen R, Skaane P, Engelstad KS, Ekeberg Ø (2013)
    Recall mammography and psychological distress
    Eur J Cancer, 49 (4), 805-11
    PubMed 23021930
57. Skretting A, Evensen JF, Løndalen AM, Bogsrud TV, Glomset OK, Eilertsen K (2013)
    A gel tumour phantom for assessment of the accuracy of manual and automatic delineation of gross tumour volume from FDG-PET/CT
    Acta Oncol, 52 (3), 636-44
    PubMed 23075421
58. Sorbye H, Welin S, Langer SW, Vestermark LW, Holt N, Osterlund P, Dueland S, Hofsli E, Guren MG, Ohrling K, Birkemeyer E, Thiis-Evensen E, Biagini M, Gronbaek H, Soveri LM, Olsen IH, Federspiel B, Assmus J, Janson ET, Knigge U (2013)
    Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study
    Ann Oncol, 24 (1), 152-60
    PubMed 22967994
59. Steinsvik EA, Axcrona K, Angelsen A, Beisland C, Dahl A, Eri LM, Haug ES, Svindland A, Fosså S (2013)
    Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study
    Scand J Urol, 47 (2), 92-100
    PubMed 22860630
60. Synnestvedt M, Borgen E, Russnes HG, Kumar NT, Schlichting E, Giercksky KE, Kåresen R, Nesland JM, Naume B (2013)
    Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy
    Acta Oncol, 52 (1), 91-101
    PubMed 22934555
61. Synnestvedt M, Borgen E, Schlichting E, Schirmer CB, Renolen A, Giercksky KE, Nesland JM, Naume B (2013)
    Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome
    Breast Cancer Res Treat, 138 (2), 485-97
    PubMed 23456230
62. Torp S, Nielsen RA, Fosså SD, Gudbergsson SB, Dahl AA (2013)
    Change in employment status of 5-year cancer survivors
    Eur J Public Health, 23 (1), 116-22
    PubMed 22227027
63. Tørris C, Thune I, Emaus A, Finstad SE, Bye A, Furberg AS, Barrett E, Jasienska G, Ellison P, Hjartåker A (2013)
    Duration of lactation, maternal metabolic profile, and body composition in the Norwegian EBBA I-study
    Breastfeed Med, 8 (1), 8-15
    PubMed 23057641
64. Valeberg BT, Grov EK (2013)
    Symptoms in the cancer patient: of importance for their caregivers' quality of life and mental health?
    Eur J Oncol Nurs, 17 (1), 46-51
    PubMed 22386554
65. Wang P, Gao Q, Suo Z, Munthe E, Solberg S, Ma L, Wang M, Westerdaal NA, Kvalheim G, Gaudernack G (2013)
    Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines
    PLoS One, 8 (3), e57020
    PubMed 23469181
66. Westgaard A, Pomianowska E, Clausen OP, Gladhaug IP (2013)
    Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Ann Surg Oncol, 20 (2), 430-9
    PubMed 22956064

Publications 2012

1. Abbas N, Bruland ØS, Brevik EM, Dahle J (2012)
   Preclinical evaluation of 227Th-labeled and 177Lu-labeled trastuzumab in mice with HER-2-positive ovarian cancer xenografts
   Nucl Med Commun, 33 (8), 838-47
   PubMed 22643311
2. Abrahamsen IW, Kjellevoll S, Greve-Isdahl M, Mensali N, Wälchli S, Kumari S, Loland BF, Egeland T, Kolstad A, Olweus J (2012)
   T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells
   Int J Cancer, 130 (8), 1821-32
   PubMed 21630262
3. Andersen MH, Dueland S, Hagness M, Vidnes T, Finstad ED, Wahl AK, Foss A (2012)
   Quality of life following liver transplantation in patients with liver metastases from colorectal carcinoma
   Scand J Caring Sci, 26 (4), 713-9
   PubMed 22452269
4. Andreassen TN, Eftedal I, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O (2012)
   Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
   Eur J Clin Pharmacol, 68 (1), 55-64
   PubMed 21735164
5. Andreassen TN, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O (2012)
   Is oxycodone efficacy reflected in serum concentrations? A multicenter, cross-sectional study in 456 adult cancer patients
   J Pain Symptom Manage, 43 (4), 694-705
   PubMed 22285284
6. Arvold ND, Catalano PJ, Sweeney CJ, Hoffman KE, Nguyen PL, Balboni TA, Fosså SD, Travis LB, Beard CJ (2012)
   Barriers to the implementation of surveillance for stage I testicular seminoma
   Int J Radiat Oncol Biol Phys, 84 (2), 383-9
   PubMed 22349043
7. Bennett MI, Rayment C, Hjermstad M, Aass N, Caraceni A, Kaasa S (2012)
   Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review
   Pain, 153 (2), 359-65
   PubMed 22115921
8. Bentzen AG, Guren MG, Wanderås EH, Frykholm G, Tveit KM, Wilsgaard T, Dahl O, Balteskard L (2012)
   Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort
   Int J Radiat Oncol Biol Phys, 83 (2), e173-80
   PubMed 22436791
9. Bergh I, Aass N, Haugen DF, Kaasa S, Hjermstad MJ (2012)
   Symptom assessment in palliative medicine
   Tidsskr Nor Laegeforen, 132 (1), 18-9
   PubMed 22240824
10. Bjerkehagen B, Småstuen MC, Hall KS, Skjeldal S, Smeland S, Fosså SD (2012)
    Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival?
    Br J Cancer, 106 (2), 297-306
    PubMed 22173669
11. Blix ES, Irish JM, Husebekk A, Delabie J, Forfang L, Tierens AM, Myklebust JH, Kolstad A (2012)
    Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
    BMC Cancer, 12, 478
    PubMed 23072591
12. Blix ES, Irish JM, Husebekk A, Delabie J, Tierens AM, Myklebust JH, Kolstad A (2012)
    Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients
    Br J Haematol, 159 (5), 604-8
    PubMed 23043253
13. Boye K, Nesland JM, Sandstad B, Haugland Haugen M, Mælandsmo GM, Flatmark K (2012)
    EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer
    Br J Cancer, 107 (4), 667-74
    PubMed 22782346
14. Brabrand S, Fosså SD, Cvancarova M, Axcrona U, Lehne G (2012)
    Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer
    J Clin Oncol, 30 (32), 4004-10
    PubMed 23071246
15. Brandberg Y, Aamdal S, Bastholt L, Hernberg M, Stierner U, von der Maase H, Hansson J (2012)
    Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b
    Eur J Cancer, 48 (13), 2012-9
    PubMed 22196968
16. Brustugun OT, Helland Å, Fjellbirkeland L, Kleinberg L, Ariansen S, Jebsen P, Scott H, Dønnem T, Bremnes R, Berg T, Grønberg BH, Dai HY, Wahl SG, Mangseth K, Helgeland L (2012)
    [Mutation testing for non-small-cell lung cancer]
    Tidsskr Nor Laegeforen, 132 (8), 952-5
    PubMed 22562326
17. Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Bjøro T, Wentzel-Larsen T, Dahl O, Norwegian Urology Cancer Group (NUCG) III study group (2012)
    Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer
    Br J Cancer, 107 (11), 1833-9
    PubMed 23169336
18. Brændengen M, Tveit KM, Hjermstad MJ, Johansson H, Berglund Å, Brandberg Y, Glimelius B (2012)
    Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a phase III study
    Eur J Cancer, 48 (6), 813-9
    PubMed 21782418
19. Bukowski R, Chlebowski RT, Thune I, Furberg AS, Hankins GD, Malone FD, D'Alton ME (2012)
    Birth weight, breast cancer and the potential mediating hormonal environment
    PLoS One, 7 (7), e40199
    PubMed 22815728
20. Bøhn SK, Russnes KM, Sakhi AK, Thoresen M, Holden M, Moskaug JØ, Myhrstad MC, Olstad OK, Smeland S, Blomhoff R (2012)
    Stress associated gene expression in blood cells is related to outcome in radiotherapy treated head and neck cancer patients
    BMC Cancer, 12, 426
    PubMed 23009663
21. d'Amore F, Relander T, Lauritzsen GF, Jantunen E, Hagberg H, Anderson H, Holte H, Österborg A, Merup M, Brown P, Kuittinen O, Erlanson M, Østenstad B, Fagerli UM, Gadeberg OV, Sundström C, Delabie J, Ralfkiaer E, Vornanen M, Toldbod HE (2012)
    Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01
    J Clin Oncol, 30 (25), 3093-9
    PubMed 22851556
22. Dahl AA, Gudbergsson SB, Dørum A, Fosså SD, Liavaag AH, Sørebø Ø (2012)
    "The impact of cancer scale" version 1: psychometric testing of the Norwegian translation in a heterogeneous sample of cancer survivors
    Qual Life Res, 21 (8), 1459-70
    PubMed 22045155
23. Daneshmand S, Albers P, Fosså SD, Heidenreich A, Kollmannsberger C, Krege S, Nichols C, Oldenburg J, Wood L (2012)
    Contemporary management of postchemotherapy testis cancer
    Eur Urol, 62 (5), 867-76
    PubMed 22938868
24. de Wit R, Skoneczna I, Daugaard G, De Santis M, Garin A, Aass N, Witjes AJ, Albers P, White JD, Germa-Lluch JR, Marreaud S, Collette L (2012)
    Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983
    J Clin Oncol, 30 (8), 792-9
    PubMed 22271474
25. Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
    Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact
    Histol Histopathol, 27 (10), 1315-25
    PubMed 22936450
26. Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
    Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness
    Histopathology, 61 (3), 350-64
    PubMed 22690749
27. Engebraaten O, Edvardsen H, Løkkevik E, Naume B, Kristensen V, Ottestad L, Natarajan V (2012)
    Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial
    ISRN Oncol, 2012, 176789
    PubMed 22666610
28. Engesæter B, Engebraaten O, Flørenes VA, Mælandsmo GM (2012)
    Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma
    PLoS One, 7 (9), e45492
    PubMed 23029050
29. Flaherty KT, Robert C, Hersey P, Nathan P, Garbe C, Milhem M, Demidov LV, Hassel JC, Rutkowski P, Mohr P, Dummer R, Trefzer U, Larkin JM, Utikal J, Dreno B, Nyakas M, Middleton MR, Becker JC, Casey M, Sherman LJ, Wu FS, Ouellet D, Martin AM, Patel K, Schadendorf D et al. (2012)
    Improved survival with MEK inhibition in BRAF-mutated melanoma
    N Engl J Med, 367 (2), 107-14
    PubMed 22663011
30. Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE, Dybedal I, Holte H, Heldal D, Torfoss D, Aurlien E, Lauritzsen GF, Fosså A, Lehne G, Baggerød E, Kvalheim G, Egeland T, Bishop MR, Fowler DH, Kolstad A (2012)
    Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation
    Bone Marrow Transplant, 47 (12), 1552-7
    PubMed 22522568
31. Fløtten Ø, Grønberg BH, Bremnes R, Amundsen T, Sundstrøm S, Rolke H, Hornslien K, Wentzel-Larsen T, Aasebø U, von Plessen C (2012)
    Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group
    Br J Cancer, 107 (3), 442-7
    PubMed 22759880
32. Fosså A, Fiskvik IH, Kolstad A, Lauritzsen GF, Aurlien E, Blystad AK, Hole KH, Ikonomou IM, Holte H (2012)
    Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosis
    Ann Oncol, 23 (5), 1254-9
    PubMed 21926399
33. Frøen H, Brennhovd B, Abeler VM, Madsbu UE, Lehne G (2012)
    [Young man with severe back pain]
    Tidsskr Nor Laegeforen, 132 (14), 1626-9
    PubMed 22875130
34. Fung C, Fossa SD, Beard CJ, Travis LB (2012)
    Second malignant neoplasms in testicular cancer survivors
    J Natl Compr Canc Netw, 10 (4), 545-56
    PubMed 22491051
35. Geisler CH, Kolstad A, Laurell A, Jerkeman M, Raty R, Andersen NS, Pedersen LB, Eriksson M, Nordstrom M, Kimby E, Bentzen H, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Ehinger M, Sundstrom C, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E, Nordic Lymphoma Grp (2012)
    Nordic MCL2 Trial Update: 6-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC Plus autologous stem-cell support: still very long survival but late relapses do occur (vol 158, pg 355, 2012)
    Br. J. Haematol., 158 (6), 815-816
36. Geisler CH, Kolstad A, Laurell A, Jerkeman M, Räty R, Andersen NS, Pedersen LB, Eriksson M, Nordström M, Kimby E, Bentzen H, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Ehinger M, Sundström C, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E, Nordic Lymphoma Group (2012)
    Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur
    Br J Haematol, 158 (3), 355-62
    PubMed 22640180
37. Grov EK, Valeberg BT (2012)
    Does the cancer patient's disease stage matter? A comparative study of caregivers' mental health and health related quality of life
    Palliat Support Care, 10 (3), 189-96
    PubMed 22436126
38. Hamfjord J, Stangeland AM, Hughes T, Skrede ML, Tveit KM, Ikdahl T, Kure EH (2012)
    Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing
    PLoS One, 7 (4), e34150
    PubMed 22529906
39. Hamre H, Kiserud CE, Ruud E, Thorsby PM, Fosså SD (2012)
    Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study
    Pediatr Blood Cancer, 59 (2), 271-7
    PubMed 22021108
40. Hauglann B, Benth J?, Fosså SD, Dahl AA (2012)
    A cohort study of permanently reduced work ability in breast cancer patients
    J Cancer Surviv, 6 (3), 345-56
    PubMed 22457217
41. Haugnes HS, Bosl GJ, Boer H, Gietema JA, Brydøy M, Oldenburg J, Dahl AA, Bremnes RM, Fosså SD (2012)
    Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up
    J Clin Oncol, 30 (30), 3752-63
    PubMed 23008318
42. Heck SL, Gulati G, Ree AH, Schulz-Menger J, Gravdehaug B, Røsjø H, Steine K, Bratland A, Hoffmann P, Geisler J, Omland T (2012)
    Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial
    Cardiology, 123 (4), 240-7
    PubMed 23207160
43. Helland Å, Solberg S, Brustugun OT (2012)
    Incidence and survival of malignant pleural mesothelioma in norway: a population-based study of 1686 cases
    J Thorac Oncol, 7 (12), 1858-61
    PubMed 23154557
44. Hjermstad MJ, Bergenmar M, Fisher SE, Montel S, Nicolatou-Galitis O, Raber-Durlacher J, Singer S, Verdonck-de Leeuw I, Weis J, Yarom N, Herlofson BB (2012)
    The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients
    Eur J Cancer, 48 (14), 2203-11
    PubMed 22572480
45. Hjermstad MJ, Lie HC, Caraceni A, Currow DC, Fainsinger RL, Gundersen OE, Haugen DF, Heitzer E, Radbruch L, Stone PC, Strasser F, Kaasa S, Loge JH, European Palliative Care Research Collaborative (EPCRC) (2012)
    Computer-based symptom assessment is feasible in patients with advanced cancer: results from an international multicenter study, the EPCRC-CSA
    J Pain Symptom Manage, 44 (5), 639-54
    PubMed 22795905
46. Hofsø K, Miaskowski C, Bjordal K, Cooper BA, Rustøen T (2012)
    Previous chemotherapy influences the symptom experience and quality of life of women with breast cancer prior to radiation therapy
    Cancer Nurs, 35 (3), 167-77
    PubMed 21760482
47. Hoivik ML, Moum B, Solberg IC, Cvancarova M, Hoie O, Vatn MH, Bernklev T, IBSEN Study Group (2012)
    Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study
    Inflamm Bowel Dis, 18 (8), 1540-9
    PubMed 21936030
48. Holmboe L, Andersen AM, Mørkrid L, Slørdal L, Hall KS (2012)
    High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients
    Br J Clin Pharmacol, 73 (1), 106-14
    PubMed 21707700
49. Huuse EM, Moestue SA, Lindholm EM, Bathen TF, Nalwoga H, Krüger K, Bofin A, Maelandsmo GM, Akslen LA, Engebraaten O, Gribbestad IS (2012)
    In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts
    J Magn Reson Imaging, 35 (5), 1098-107
    PubMed 22170753
50. Høivik ML, Bernklev T, Solberg IC, Cvancarova M, Lygren I, Jahnsen J, Moum B, IBSEN Study Group (2012)
    Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: ten-year results from the IBSEN study
    J Crohns Colitis, 6 (4), 441-53
    PubMed 22398064
51. Haas RL, Delaney TF, O'Sullivan B, Keus RB, Le Pechoux C, Olmi P, Poulsen JP, Seddon B, Wang D (2012)
    Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where?
    Int J Radiat Oncol Biol Phys, 84 (3), 572-80
    PubMed 22520481
52. Håvik AB, Brandal P, Honne H, Dahlback HS, Scheie D, Hektoen M, Meling TR, Helseth E, Heim S, Lothe RA, Lind GE (2012)
    MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
    J Transl Med, 10, 36
    PubMed 22390413
53. Ingebrigtsen VA, Boye K, Tekle C, Nesland JM, Flatmark K, Fodstad O (2012)
    B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer
    Int J Cancer, 131 (11), 2528-36
    PubMed 22473715
54. Iversen A, Thune I, McTiernan A, Makar KW, Wilsgaard T, Ellison PT, Jasienska G, Flote V, Poole EM, Furberg AS (2012)
    Genetic polymorphism CYP17 rs2486758 and metabolic risk factors predict daily salivary 17?-estradiol concentration in healthy premenopausal Norwegian women. The EBBA-I study
    J Clin Endocrinol Metab, 97 (5), E852-7
    PubMed 22419734
55. Joensuu H, Eriksson M, Sundby Hall K, Hartmann JT, Pink D, Schütte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran SE, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Monge OR, Bono P, Kallio R, Vehtari A, Leinonen M, Alvegård T, Reichardt P (2012)
    One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial
    JAMA, 307 (12), 1265-72
    PubMed 22453568
56. Jóhannsdóttir IM, Hjermstad MJ, Moum T, Wesenberg F, Hjorth L, Schrøder H, Mört S, Jónmundsson G, Loge JH (2012)
    Increased prevalence of chronic fatigue among survivors of childhood cancers: a population-based study
    Pediatr Blood Cancer, 58 (3), 415-20
    PubMed 21425447
57. Johnson E, Førland DT, Hetland G, Sætre L, Olstad OK, Lyberg T (2012)
    Effect of AndoSan? on expression of adhesion molecules and production of reactive oxygen species in human monocytes and granulocytes in vivo
    Scand J Gastroenterol, 47 (8-9), 984-92
    PubMed 22564240
58. Jørgensen KK, Lindström L, Cvancarova M, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM (2012)
    Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study
    Scand J Gastroenterol, 47 (8-9), 1021-9
    PubMed 22577871
59. Kaye S, Aamdal S, Jones R, Freyer G, Pujade-Lauraine E, de Vries EG, Barriuso J, Sandhu S, Tan DS, Hartog V, Kuenen B, Ruijter R, Kristensen GB, Nyakas M, Barrett S, Burke W, Pietersma D, Stuart M, Emeribe U, Boven E (2012)
    Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours
    Br J Cancer, 106 (11), 1728-34
    PubMed 22531637
60. Kjersem JB, Ikdahl T, Guren T, Skovlund E, Sorbye H, Hamfjord J, Pfeiffer P, Glimelius B, Kersten C, Solvang H, Tveit KM, Kure EH (2012)
    Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab
    BMC Cancer, 12, 534
    PubMed 23167843
61. Knappskog S, Chrisanthar R, Løkkevik E, Anker G, Østenstad B, Lundgren S, Risberg T, Mjaaland I, Leirvaag B, Miletic H, Lønning PE (2012)
    Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
    Breast Cancer Res, 14 (2), R47
    PubMed 22420423
62. Knappskog S, Gansmo LB, Romundstad P, Bjørnslett M, Trovik J, Sommerfelt-Pettersen J, Løkkevik E, Norwegian Breast Cancer Group trial NBCG VI, Tollenaar RA, Seynaeve C, Devilee P, Salvesen HB, Dørum A, Hveem K, Vatten L, Lønning PE (2012)
    MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk
    PLoS One, 7 (4), e36263
    PubMed 22558411
63. Knudsen AK, Brunelli C, Klepstad P, Aass N, Apolone G, Corli O, Montanari M, Caraceni A, Kaasa S (2012)
    Which domains should be included in a cancer pain classification system? Analyses of longitudinal data
    Pain, 153 (3), 696-703
    PubMed 22264677
64. Knudsen AK, Klepstad P, Caraceni A, Kaasa S, Brunelli C, Aass N, Apolone G, Corli O, Montanari M (2012)
    Cancer pain undertreatment and prognostic factors Response
    Pain, 153 (8), 1771-1772
65. Knudsen AK, Aass N, Heitzer E, Klepstad P, Hjermstad MJ, Schippinger W, Brenne E, Kaasa S, Wasteson E, European Palliative Care Research Collaborative (EPCRC) (2012)
    Interviews with patients with advanced cancer--another step towards an international cancer pain classification system
    Support Care Cancer, 20 (10), 2491-500
    PubMed 22252546
66. Kristensen VN, Vaske CJ, Ursini-Siegel J, Van Loo P, Nordgard SH, Sachidanandam R, Sørlie T, Wärnberg F, Haakensen VD, Helland Å, Naume B, Perou CM, Haussler D, Troyanskaya OG, Børresen-Dale AL (2012)
    Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling
    Proc Natl Acad Sci U S A, 109 (8), 2802-7
    PubMed 21908711
67. Kristiansen W, Andreassen KE, Karlsson R, Aschim EL, Bremnes RM, Dahl O, Fosså SD, Klepp O, Langberg CW, Solberg A, Tretli S, Adami HO, Wiklund F, Grotmol T, Haugen TB (2012)
    Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population
    Hum Reprod, 27 (5), 1525-35
    PubMed 22402210
68. Kristiansen W, Aschim EL, Andersen JM, Witczak O, Fosså SD, Haugen TB (2012)
    Variations in testosterone pathway genes and susceptibility to testicular cancer in Norwegian men
    Int J Androl, 35 (6), 819-27
    PubMed 22882535
69. Kristjansson SR, Ronning B, Hurria A, Skovlund E, Jordhoy MS, Nesbakken A, Wyller TB (2012)
    A comparison of two pre-operative frailty measures in older surgical cancer patients
    J. Geriatr. Oncol., 3 (1), 1-7
70. Kure EH, Hamfjord J, Stangeland AM, Tveit KM, Ikdahl T (2012)
    KRAS mutational test for metastatic colorectal cancer patients: not just a technical problem
    Expert Rev Mol Diagn, 12 (4), 327-8
    PubMed 22616697
71. Langmoen IA, Foss A, Kvalheim G, Engebretsen L, Glover JC (2012)
    [Stem cell research--new hope?]
    Tidsskr Nor Laegeforen, 132 (23-24), 2584
    PubMed 23338066
72. Lilleby W, Tafjord G, Raabe NK (2012)
    Implementation of high-dose-rate brachytherapy and androgen deprivation in patients with prostate cancer
    Int J Radiat Oncol Biol Phys, 83 (3), 933-9
    PubMed 22138456
73. Lilleby W, Willoch F, Stensvold A (2012)
    Detection of prostate cancer relapse with PET/CT using a novel radiotracer
    Acta Oncol, 51 (3), 397-9
    PubMed 21936756
74. Lindbohm ML, Taskila T, Kuosma E, Hietanen P, Carlsen K, Gudbergsson S, Gunnarsdottir H (2012)
    Work ability of survivors of breast, prostate, and testicular cancer in Nordic countries: a NOCWO study
    J Cancer Surviv, 6 (1), 72-81
    PubMed 22042662
75. Lindholm EM, Kristian A, Nalwoga H, Krüger K, Nygård S, Akslen LA, Mælandsmo GM, Engebraaten O (2012)
    Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts
    Mol Oncol, 6 (4), 418-27
    PubMed 22521242
76. Luksch R, Tienghi A, Hall KS, Fagioli F, Picci P, Barbieri E, Gandola L, Eriksson M, Ruggieri P, Daolio P, Lindholm P, Prete A, Bisogno G, Tamburini A, Grignani G, Abate ME, Podda M, Smeland S, Ferrari S (2012)
    Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation
    Ann Oncol, 23 (11), 2970-6
    PubMed 22771824
77. Lund-Iversen M, Kleinberg L, Fjellbirkeland L, Helland Å, Brustugun OT (2012)
    Clinicopathological characteristics of 11 NSCLC patients with EGFR-exon 20 mutations
    J Thorac Oncol, 7 (9), 1471-3
    PubMed 22895145
78. Lægreid IK, Bye A, Aasarød K, Jordhøy M (2012)
    Nutritional problems, overhydration and the association with quality of life in elderly dialysis patients
    Int Urol Nephrol, 44 (6), 1885-92
    PubMed 23001608
79. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Giercksky KE, Nesland JM, Suo Z (2012)
    Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines
    Tumour Biol, 33 (4), 967-78
    PubMed 22252524
80. Mathiesen RR, Borgen E, Renolen A, Løkkevik E, Nesland JM, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Kvalheim G, Lønning PE, Naume B (2012)
    Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival
    Breast Cancer Res, 14 (4), R117
    PubMed 22889108
81. Mathiesen RR, Fjelldal R, Liestøl K, Due EU, Geigl JB, Riethdorf S, Borgen E, Rye IH, Schneider IJ, Obenauf AC, Mauermann O, Nilsen G, Christian Lingjaerde O, Børresen-Dale AL, Pantel K, Speicher MR, Naume B, Baumbusch LO (2012)
    High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer
    Int J Cancer, 131 (4), E405-15
    PubMed 21935921
82. Meulenbeld HJ, van Werkhoven ED, Coenen JL, Creemers GJ, Loosveld OJ, de Jong PC, Ten Tije AJ, Fosså SD, Polee M, Gerritsen W, Dalesio O, de Wit R (2012)
    Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)
    Eur J Cancer, 48 (16), 2993-3000
    PubMed 22677260
83. Micu E, Baturaite Z, Juzeniene A, Bruland ØS, Moan JE (2012)
    Superficial-spreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients
    Melanoma Res, 22 (6), 460-5
    PubMed 23010822
84. Mitrovic Z, Perry AM, Suzumiya J, Armitage JO, Au WY, Coiffier B, Holte H, Jaffe ES, Monserrat E, Rajan SK, Savage KJ, Tobinai K, Vose JM, Weisenburger DD (2012)
    The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project
    Am J Hematol, 87 (8), 790-4
    PubMed 22488678
85. Molloy TJ, Roepman P, Naume B, van't Veer LJ (2012)
    A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patients
    PLoS One, 7 (2), e32426
    PubMed 22384245
86. Mortensen HR, Overgaard J, Specht L, Overgaard M, Johansen J, Evensen JF, Andersen LJ, Andersen E, Grau C (2012)
    Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer
    Radiother Oncol, 103 (1), 69-75
    PubMed 22398313
87. Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, Holowaty EJ, Lynch CF, Curtis RE, Smith SA, Kleinerman RA, Kaijser M, Storm HH, Pukkala E, Weathers RE, Linet MS, Rajaraman P, Fraumeni JF, Brown LM, van Leeuwen FE, Fossa SD, Johannesen TB, Langmark F et al. (2012)
    Risk of treatment-related esophageal cancer among breast cancer survivors
    Ann Oncol, 23 (12), 3081-91
    PubMed 22745217
88. Myklebust MP, Fluge Ø, Immervoll H, Skarstein A, Balteskard L, Bruland O, Dahl O (2012)
    Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients
    Br J Cancer, 106 (4), 756-62
    PubMed 22333708
89. Myklebust MP, Li Z, Tran TH, Rui H, Knudsen ES, Elsaleh H, Fluge Ø, Vonen B, Myrvold HE, Leh S, Tveit KM, Pestell RG, Dahl O (2012)
    Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer
    Br J Cancer, 107 (10), 1684-91
    PubMed 23099809
90. Namløs HM, Kresse SH, Müller CR, Henriksen J, Holdhus R, Sæter G, Bruland OS, Bjerkehagen B, Steen VM, Myklebost O (2012)
    Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern
    Sarcoma, 2012, 639038
    PubMed 22518090
91. Nilsen G, Liestøl K, Van Loo P, Moen Vollan HK, Eide MB, Rueda OM, Chin SF, Russell R, Baumbusch LO, Caldas C, Børresen-Dale AL, Lingjaerde OC (2012)
    Copynumber: Efficient algorithms for single- and multi-track copy number segmentation
    BMC Genomics, 13, 591
    PubMed 23442169
92. Nilsson S, Strang P, Aksnes AK, Franzèn L, Olivier P, Pecking A, Staffurth J, Vasanthan S, Andersson C, Bruland ØS (2012)
    A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer
    Eur J Cancer, 48 (5), 678-86
    PubMed 22341993
93. Nordbø A, Skurtveit S, Borchgrevink PC, Kaasa S, Fredheim OM (2012)
    Low-dose transdermal buprenorphine - long-term use and co-medication with other potentially addictive drugs
    Acta Anaesthesiol Scand, 56 (1), 88-94
    PubMed 22092357
94. Nordlund MS, Stieber P, Brustugun OT, Warren DJ, Paus E (2012)
    Characteristics and clinical validity of two immunoassays for ProGRP
    Tumour Biol, 33 (4), 1105-13
    PubMed 22399443
95. Nyquist KB, Panagopoulos I, Thorsen J, Haugom L, Gorunova L, Bjerkehagen B, Fosså A, Guriby M, Nome T, Lothe RA, Skotheim RI, Heim S, Micci F (2012)
    Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma
    PLoS One, 7 (11), e49705
    PubMed 23185413
96. Olsen K, Falch BM, Danielsen K, Johannessen M, Ericson Sollid JU, Thune I, Grimnes G, Jorde R, Simonsen GS, Furberg AS (2012)
    Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromsø Staph and Skin Study
    Eur J Clin Microbiol Infect Dis, 31 (4), 465-73
    PubMed 21811869
97. Olssøn I, Dahl AA (2012)
    Avoidant personality problems--their association with somatic and mental health, lifestyle, and social network. A community-based study
    Compr Psychiatry, 53 (6), 813-21
    PubMed 22146705
98. Olweus J, Kolstad A (2012)
    [Can the immune system target cancer?]
    Tidsskr Nor Laegeforen, 132 (7), 784-5
    PubMed 22511078
99. Opheim R, Bernklev T, Fagermoen MS, Cvancarova M, Moum B (2012)
    Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway
    Scand J Gastroenterol, 47 (12), 1436-47
    PubMed 23003678
100. Peifer M, Fernández-Cuesta L, Sos ML, George J, Seidel D, Kasper LH, Plenker D, Leenders F, Sun R, Zander T, Menon R, Koker M, Dahmen I, Müller C, Di Cerbo V, Schildhaus HU, Altmüller J, Baessmann I, Becker C, de Wilde B, Vandesompele J, Böhm D, Ansén S, Gabler F, Wilkening I et al. (2012)
     Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
     Nat Genet, 44 (10), 1104-10
     PubMed 22941188
101. Pomianowska E, Grzyb K, Westgaard A, Clausen OP, Gladhaug IP (2012)
     Reclassification of tumour origin in resected periampullary adenocarcinomas reveals underestimation of distal bile duct cancer
     Eur J Surg Oncol, 38 (11), 1043-50
     PubMed 22883964
102. Ree AH, Kristensen AT, Saelen MG, de Wijn R, Edvardsen H, Jovanovic J, Abrahamsen TW, Dueland S, Flatmark K (2012)
     Tumor phosphatidylinositol-3-kinase signaling and development of metastatic disease in locally advanced rectal cancer
     PLoS One, 7 (11), e50806
     PubMed 23226389
103. Riihijärvi S, Nurmi H, Holte H, Björkholm M, Fluge O, Pedersen LM, Rydström K, Jerkeman M, Eriksson M, Leppä S (2012)
     High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy
     Eur J Haematol, 89 (5), 395-402
     PubMed 22882209
104. Rogne SG, Rønning P, Helseth E, Johannesen TB, Langberg CW, Lote K, Scheie D, Meling TR (2012)
     Craniotomy for brain metastases: a consecutive series of 316 patients
     Acta Neurol Scand, 126 (1), 23-31
     PubMed 21902675
105. Rud AK, Lund-Iversen M, Berge G, Brustugun OT, Solberg SK, Mælandsmo GM, Boye K (2012)
     Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
     BMC Cancer, 12, 333
     PubMed 22853000
106. Rustøen T, Valeberg BT, Kolstad E, Wist E, Paul S, Miaskowski C (2012)
     The PRO-SELF(©) Pain Control Program improves patients' knowledge of cancer pain management
     J Pain Symptom Manage, 44 (3), 321-30
     PubMed 22704056
107. Ruud E, Kanellopoulos A, Zeller B, Widing E, Tjønnfjord GE, Fosså SD (2012)
     Patient knowledge of late effects of acute lymphoblastic leukaemia
     Tidsskr Nor Laegeforen, 132 (18), 2052-5
     PubMed 23038194
108. Sagerup CM, Småstuen M, Johannesen TB, Helland A, Brustugun OT (2012)
     Increasing age and carcinoma not otherwise specified: a 20-year population study of 40,118 lung cancer patients
     J Thorac Oncol, 7 (1), 57-63
     PubMed 21900838
109. Sand K, Eik-Nes NL, Loge JH (2012)
     Readability of informed consent documents (1987-2007) for clinical trials: a linguistic analysis
     J Empir Res Hum Res Ethics, 7 (4), 67-78
     PubMed 23086049
110. Schee K, Boye K, Abrahamsen TW, Fodstad Ø, Flatmark K (2012)
     Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
     BMC Cancer, 12, 505
     PubMed 23121918
111. Schee K, Flatmark K, Holm R, Boye K, Paus E (2012)
     Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients (vol 33, pg 73, 2012)
     Tumor Biol., 33 (4), 1263-1264
112. Schee K, Flatmark K, Holm R, Boye K, Paus E (2012)
     Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
     Tumour Biol, 33 (1), 73-83
     PubMed 22006279
113. Schmidt M, Småstuen MC, Søndenaa K (2012)
     Increased cancer incidence in some gallstone diseases, and equivocal effect of cholecystectomy: a long-term analysis of cancer and mortality
     Scand J Gastroenterol, 47 (12), 1467-74
     PubMed 22946484
114. Sorensen T, Dahl AA, Fossa SD, Holmen J, Lien L, Danbolt LJ (2012)
     Is 'Seeking God's Help' Associated with Life Satisfaction and Disease-specific Quality of Life in Cancer Patients? The HUNT Study
     Arch. Psychol. Relig., 34 (2), 191-213
115. Sprauten M, Darrah TH, Peterson DR, Campbell ME, Hannigan RE, Cvancarova M, Beard C, Haugnes HS, Fosså SD, Oldenburg J, Travis LB (2012)
     Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer
     J Clin Oncol, 30 (3), 300-7
     PubMed 22184390
116. Steindal SA, Sørbye LW, Bredal IS, Lerdal A (2012)
     Agreement in documentation of symptoms, clinical signs, and treatment at the end of life: a comparison of data retrieved from nurse interviews and electronic patient records using the Resident Assessment Instrument for Palliative Care
     J Clin Nurs, 21 (9-10), 1416-24
     PubMed 22023535
117. Steinsvik EA, Axcrona K, Dahl AA, Eri LM, Stensvold A, Fosså SD (2012)
     Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother
     BJU Int, 109 (9), 1366-74
     PubMed 21999333
118. Stensvold A, Dahl AA, Brennhovd B, Cvancarova M, Fosså SD, Lilleby W, Axcrona K, Smeland S (2012)
     Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones
     Prostate, 72 (6), 668-76
     PubMed 21809351
119. Svensson E, Beiske AG, Loge JH, Beiske KK, Sivertsen B (2012)
     Sleep problems in Parkinson's disease: a community-based study in Norway
     BMC Neurol, 12, 71
     PubMed 22883600
120. Synnestvedt M, Borgen E, Wist E, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Schirmer C, Nesland JM, Naume B (2012)
     Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study
     BMC Cancer, 12, 616
     PubMed 23259667
121. Syse A, Aas GB, Loge JH (2012)
     Children and young adults with parents with cancer: a population-based study
     Clin Epidemiol, 4, 41-52
     PubMed 22442635
122. Sørensen O, Flatmark K, Reed W, Wiig JN, Dueland S, Giercksky KE, Larsen SG (2012)
     Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei
     Eur J Surg Oncol, 38 (10), 969-76
     PubMed 22763244
123. Thorsen L, Nilsen TS, Raastad T, Courneya KS, Skovlund E, Fosså SD (2012)
     A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design
     BMC Cancer, 12, 123
     PubMed 22458865
124. Torfoss D, Høiby EA, Holte H, Kvaløy S (2012)
     The Norwegian experience with penicillin G plus an aminoglycoside as initial empiric therapy in febrile neutropenia; a review
     Acta Oncol, 51 (4), 433-40
     PubMed 22175253
125. Torp S, Nielsen RA, Gudbergsson SB, Dahl AA (2012)
     Worksite adjustments and work ability among employed cancer survivors
     Support Care Cancer, 20 (9), 2149-56
     PubMed 22086407
126. Torp S, Nielsen RA, Gudbergsson SB, Fosså SD, Dahl AA (2012)
     Sick leave patterns among 5-year cancer survivors: a registry-based retrospective cohort study
     J Cancer Surviv, 6 (3), 315-23
     PubMed 22706884
127. Tveit KM, Guren T, Glimelius B, Pfeiffer P, Sorbye H, Pyrhonen S, Sigurdsson F, Kure E, Ikdahl T, Skovlund E, Fokstuen T, Hansen F, Hofsli E, Birkemeyer E, Johnsson A, Starkhammar H, Yilmaz MK, Keldsen N, Erdal AB, Dajani O, Dahl O, Christoffersen T (2012)
     Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study
     J Clin Oncol, 30 (15), 1755-62
     PubMed 22473155
128. Tveteraas IH, Müller KM, Aasrum M, Ødegård J, Dajani O, Guren T, Sandnes D, Christoffersen T (2012)
     Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells
     J Exp Clin Cancer Res, 31, 72
     PubMed 22967907
129. Vistad I, Cvancarova M, Salvesen HB (2012)
     Follow-up of gynecological cancer patients after treatment - the views of European experts in gynecologic oncology
     Acta Obstet Gynecol Scand, 91 (11), 1286-92
     PubMed 22880840
130. Wahlin BE, Sander B, Christensson B, Ostenstad B, Holte H, Brown PD, Sundström C, Kimby E (2012)
     Entourage: the immune microenvironment following follicular lymphoma
     Blood Cancer J, 2 (1), e52
     PubMed 22829236
131. Wahlin BE, Yri OE, Kimby E, Holte H, Delabie J, Smeland EB, Sundström C, Christensson B, Sander B (2012)
     Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times
     Br J Haematol, 156 (2), 225-33
     PubMed 22126847
132. Waldeland E, Brustugun OT, Ramberg C, Helland Å (2012)
     [Stereotactic irradiation in spinal metastases]
     Tidsskr Nor Laegeforen, 132 (22), 2478-9
     PubMed 23338027
133. Waldeland E, Ramberg C, Arnesen MR, Helland A, Brustugun OT, Malinen E (2012)
     Dosimetric impact of a frame-based strategy in stereotactic radiotherapy of lung tumors
     Acta Oncol, 51 (5), 603-9
     PubMed 22304490
134. Wien TN, Pike E, Wisløff T, Staff A, Smeland S, Klemp M (2012)
     Cancer risk with folic acid supplements: a systematic review and meta-analysis
     BMJ Open, 2 (1), e000653
     PubMed 22240654
135. Wilberg P, Hjermstad MJ, Ottesen S, Herlofson BB (2012)
     Oral health is an important issue in end-of-life cancer care
     Support Care Cancer, 20 (12), 3115-22
     PubMed 22434497
136. Wist EA, Mjaaland I, Løkkevik E, Sommer HH (2012)
     Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer
     J Oncol, 2012, 862921
     PubMed 22291703
137. Yri OE, Ekstrøm PO, Hilden V, Gaudernack G, Liestøl K, Smeland EB, Holte H (2012)
     Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma
     Leuk Lymphoma, 53 (10), 1934-44
     PubMed 22475179
138. Ziomkiewicz A, Pawlowski B, Ellison PT, Lipson SF, Thune I, Jasienska G (2012)
     Higher luteal progesterone is associated with low levels of premenstrual aggressive behavior and fatigue
     Biol Psychol, 91 (3), 376-82
     PubMed 22906865

Publications 2011

1. Abbas N, Heyerdahl H, Bruland OS, Borrebæk J, Nesland J, Dahle J (2011)
   Experimental ?-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab
   EJNMMI Res, 1 (1), 18
   PubMed 22214432
2. Abouassaly R, Fossa SD, Giwercman A, Kollmannsberger C, Motzer RJ, Schmoll HJ, Sternberg CN (2011)
   Sequelae of treatment in long-term survivors of testis cancer
   Eur Urol, 60 (3), 516-26
   PubMed 21684072
3. Almåsbak H, Rian E, Hoel HJ, Pulè M, Wälchli S, Kvalheim G, Gaudernack G, Rasmussen AM (2011)
   Transiently redirected T cells for adoptive transfer
   Cytotherapy, 13 (5), 629-40
   PubMed 21174490
4. Amdal CD, Jacobsen AB, Tausjø JE, Wiig JN, Warloe T, Sandstad B, Bjordal K (2011)
   Palliative interventions and prognosis in patients with advanced esophageal cancer
   Dis Esophagus, 24 (7), 502-9
   PubMed 21309923
5. Andersson M, Lidbrink E, Bjerre K, Wist E, Enevoldsen K, Jensen AB, Karlsson P, Tange UB, Sørensen PG, Møller S, Bergh J, Langkjer ST (2011)
   Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study
   J Clin Oncol, 29 (3), 264-71
   PubMed 21149659
6. Andreassen KE, Grotmol T, Cvancarova MS, Johannesen TB, Fosså SD (2011)
   Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953-2007)
   Int J Cancer, 129 (12), 2867-74
   PubMed 21626506
7. Andreassen TN, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O (2011)
   Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients
   Eur J Clin Pharmacol, 67 (5), 493-506
   PubMed 21140139
8. Anfinsen KP, Devesa SS, Bray F, Troisi R, Jonasdottir TJ, Bruland OS, Grotmol T (2011)
   Age-period-cohort analysis of primary bone cancer incidence rates in the United States (1976-2005)
   Cancer Epidemiol Biomarkers Prev, 20 (8), 1770-7
   PubMed 21724855
9. Anfinsen KP, Grotmol T, Bruland OS, Jonasdottir TJ (2011)
   Breed-specific incidence rates of canine primary bone tumors--a population based survey of dogs in Norway
   Can J Vet Res, 75 (3), 209-15
   PubMed 22210997
10. Berg A, Brustugun OT, Lund-Iversen M, Helland Å (2011)
    Palmar bullous blistering induced by erlotinib
    J Thorac Oncol, 6 (5), 954
    PubMed 21623268
11. Berge G, Pettersen S, Grotterød I, Bettum IJ, Boye K, Mælandsmo GM (2011)
    Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis
    Int J Cancer, 129 (4), 780-90
    PubMed 20957651
12. Berge V, Baco E, Dahl AA, Karlsen SJ (2011)
    Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer
    Int J Urol, 18 (9), 646-51
    PubMed 21771102
13. Bergh I, Kvalem IL, Aass N, Hjermstad MJ (2011)
    What does the answer mean? A qualitative study of how palliative cancer patients interpret and respond to the Edmonton Symptom Assessment System
    Palliat Med, 25 (7), 716-24
    PubMed 21248179
14. Bergland A, Thorsen H, Kåresen R (2011)
    Effect of exercise on mobility, balance, and health-related quality of life in osteoporotic women with a history of vertebral fracture: a randomized, controlled trial
    Osteoporos Int, 22 (6), 1863-71
    PubMed 21060992
15. Bernsdorf M, Ingvar C, Jörgensen L, Tuxen MK, Jakobsen EH, Saetersdal A, Kimper-Karl ML, Kroman N, Balslev E, Ejlertsen B (2011)
    Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial
    Breast Cancer Res Treat, 126 (2), 463-70
    PubMed 21234672
16. Borgan E, Navon R, Vollan HK, Schlichting E, Sauer T, Yakhini Z, Lingjærde OC, Sørlie T, Børresen-Dale AL (2011)
    Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue
    Mol Oncol, 5 (6), 564-76
    PubMed 21917534
17. Bornholdt J, Friis S, Godiksen S, Poulsen SS, Santoni-Rugiu E, Bisgaard HC, Lothe IM, Ikdahl T, Tveit KM, Johnson E, Kure EH, Vogel LK (2011)
    The level of claudin-7 is reduced as an early event in colorectal carcinogenesis
    BMC Cancer, 11, 65
    PubMed 21310043
18. Brabrand S, Fosså SD, Cvancarova M, Lehne G (2011)
    Androgen substitution with testosterone undecanoate in survivors of bilateral testicular cancer requires individually-adjusted injection intervals
    BJU Int, 107 (7), 1080-7
    PubMed 20825398
19. Bratland A, Dueland S, Hollywood D, Flatmark K, Ree AH (2011)
    Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy
    Radiat Oncol, 6, 33
    PubMed 21473790
20. Bredal IS, Sandvik L, Karesen R, Ekeberg O (2011)
    Prognostic value of health-related quality-of-life parameters in early-stage breast cancer: an 8-year follow-up study
    Psychooncology, 20 (10), 1102-7
    PubMed 20737644
21. Brunsvig PF, Kyte JA, Kersten C, Sundstrøm S, Møller M, Nyakas M, Hansen GL, Gaudernack G, Aamdal S (2011)
    Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial
    Clin Cancer Res, 17 (21), 6847-57
    PubMed 21918169
22. Brændengen M, Hansson K, Radu C, Siegbahn A, Jacobsson H, Glimelius B (2011)
    Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study
    Int J Radiat Oncol Biol Phys, 81 (4), e439-45
    PubMed 21641122
23. Brændengen M, Tveit KM, Bruheim K, Cvancarova M, Berglund Å, Glimelius B (2011)
    Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study
    Int J Radiat Oncol Biol Phys, 81 (4), 1017-24
    PubMed 20932687
24. Cameron MG, Kersten C, van Helvoirt R, Rohde G, Fosså SD, Vistad I (2011)
    Patient reported outcomes of symptoms and quality of life among cancer patients treated with palliative pelvic radiation: a pilot study
    BMC Res Notes, 4, 252
    PubMed 21777440
25. Chrisanthar R, Knappskog S, Løkkevik E, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Skjønsberg G, Aas T, Schlichting E, Fjösne HE, Nysted A, Lillehaug JR, Lønning PE (2011)
    Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel
    PLoS One, 6 (4), e19249
    PubMed 21556366
26. Dahl AA, Nesvold IL, Reinertsen KV, Fosså SD (2011)
    Arm/shoulder problems and insomnia symptoms in breast cancer survivors: cross-sectional, controlled and longitudinal observations
    Sleep Med, 12 (6), 584-90
    PubMed 21645872
27. Dahlback HS, Brandal P, Gorunova L, Widing E, Meling TR, Krossnes BK, Heim S (2011)
    Genomic aberrations in pediatric gliomas and embryonal tumors
    Genes Chromosomes Cancer, 50 (10), 788-99
    PubMed 21717527
28. Dahlback HS, Brandal P, Krossnes BK, Fric R, Meling TR, Meza-Zepeda LA, Danielsen HE, Heim S (2011)
    Multiple chromosomal monosomies are characteristic of giant cell ependymoma
    Hum Pathol, 42 (12), 2042-6
    PubMed 21683982
29. Dahlback HS, Gorunova L, Brandal P, Scheie D, Helseth E, Meling TR, Heim S (2011)
    Genomic aberrations in diffuse low-grade gliomas
    Genes Chromosomes Cancer, 50 (6), 409-20
    PubMed 21412929
30. Dahlback HS, Gorunova L, Micci F, Scheie D, Brandal P, Meling TR, Heim S (2011)
    Molecular cytogenetic analysis of a gliosarcoma with osseous metaplasia
    Cytogenet Genome Res, 134 (2), 88-95
    PubMed 21555877
31. Dahle J, Abbas N, Bruland ØS, Larsen RH (2011)
    Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates
    Curr Radiopharm, 4 (4), 321-8
    PubMed 22202154
32. Daugaard G, Skoneczna I, Aass N, De Wit R, De Santis M, Dumez H, Marreaud S, Collette L, Lluch JR, Bokemeyer C, Schmoll HJ (2011)
    A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)
    Ann Oncol, 22 (5), 1054-61
    PubMed 21059637
33. Delabie J, Holte H, Vose JM, Ullrich F, Jaffe ES, Savage KJ, Connors JM, Rimsza L, Harris NL, Müller-Hermelink K, Rüdiger T, Coiffier B, Gascoyne RD, Berger F, Tobinai K, Au WY, Liang R, Montserrat E, Hochberg EP, Pileri S, Federico M, Nathwani B, Armitage JO, Weisenburger DD (2011)
    Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project
    Blood, 118 (1), 148-55
    PubMed 21566094
34. Effenberger KE, Borgen E, Eulenburg CZ, Bartkowiak K, Grosser A, Synnestvedt M, Kaaresen R, Brandt B, Nesland JM, Pantel K, Naume B (2011)
    Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
    Breast Cancer Res Treat, 125 (3), 729-38
    PubMed 20449649
35. Eide MB, Lauritzsen GF, Kvalheim G, Kolstad A, Fagerli UM, Maisenhölder M, Østenstad B, Fluge Ø, Delabie J, Aarset H, Liestøl K, Holte H (2011)
    High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study
    Br J Haematol, 152 (5), 600-10
    PubMed 21241276
36. Elvsåshagen T, Vera E, Bøen E, Bratlie J, Andreassen OA, Josefsen D, Malt UF, Blasco MA, Boye B (2011)
    The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder
    J Affect Disord, 135 (1-3), 43-50
    PubMed 21880373
37. Emaus A, Thune I (2011)
    Physical activity and lung cancer prevention
    Recent Results Cancer Res, 186, 101-33
    PubMed 21113762
38. Emaus N, Heiberg I, Ahmed LA, Balteskard L, Jacobsen BK, Magnus T, Olsen LR, Ytterstad B (2011)
    Methodological challenges in hip fracture registration: the Harstad Injury Registry
    Int J Inj Contr Saf Promot, 18 (2), 135-42
    PubMed 21432705
39. Emaus N, Olsen LR, Ahmed LA, Balteskard L, Jacobsen BK, Magnus T, Ytterstad B (2011)
    Hip fractures in a city in Northern Norway over 15 years: time trends, seasonal variation and mortality : the Harstad Injury Prevention Study
    Osteoporos Int, 22 (10), 2603-10
    PubMed 21249333
40. Enerly E, Steinfeld I, Kleivi K, Leivonen SK, Aure MR, Russnes HG, Rønneberg JA, Johnsen H, Navon R, Rødland E, Mäkelä R, Naume B, Perälä M, Kallioniemi O, Kristensen VN, Yakhini Z, Børresen-Dale AL (2011)
    miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
    PLoS One, 6 (2), e16915
    PubMed 21364938
41. Engesæter BO, Sathermugathevan M, Hellenes T, Engebråten O, Holm R, Flørenes VA, Mælandsmo GM (2011)
    Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells
    Cancer Biol Ther, 12 (1), 47-58
    PubMed 21508672
42. Fangberget A, Nilsen LB, Hole KH, Holmen MM, Engebraaten O, Naume B, Smith HJ, Olsen DR, Seierstad T (2011)
    Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging
    Eur Radiol, 21 (6), 1188-99
    PubMed 21127880
43. Fayers PM, Hjermstad MJ, Klepstad P, Loge JH, Caraceni A, Hanks GW, Borchgrevink P, Kaasa S, European Palliative Care Research Collaborative (EPCRC) (2011)
    The dimensionality of pain: palliative care and chronic pain patients differ in their reports of pain intensity and pain interference
    Pain, 152 (7), 1608-20
    PubMed 21458921
44. Ferrari S, Sundby Hall K, Luksch R, Tienghi A, Wiebe T, Fagioli F, Alvegard TA, Brach Del Prever A, Tamburini A, Alberghini M, Gandola L, Mercuri M, Capanna R, Mapelli S, Prete A, Carli M, Picci P, Barbieri E, Bacci G, Smeland S (2011)
    Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol
    Ann Oncol, 22 (5), 1221-7
    PubMed 21059639
45. Fjösne HE, Søreide JA, Kåresen R, Lønning PE, Jacobsen AB, Lundgren S, NORWEGIAN BREAST CANCER GROUP (NBCG) (2011)
    Hospital volume and prognosis among Norwegian breast cancer patients enrolled in adjuvant trials
    Acta Oncol, 50 (7), 1068-74
    PubMed 21745131
46. Flatmark K, Borgen E, Nesland JM, Rasmussen H, Johannessen HO, Bukholm I, Rosales R, Hårklau L, Jacobsen HJ, Sandstad B, Boye K, Fodstad Ø (2011)
    Disseminated tumour cells as a prognostic biomarker in colorectal cancer
    Br J Cancer, 104 (9), 1434-9
    PubMed 21448171
47. Fløisand Y, Delabie J, Fosså A, Helseth E, Jacobsen EA, Rolke J, Tjønnfjord GE (2011)
    Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia
    Leuk Lymphoma, 52 (10), 2007-9
    PubMed 21663503
48. Fors EA, Bertheussen GF, Thune I, Juvet LK, Elvsaas IK, Oldervoll L, Anker G, Falkmer U, Lundgren S, Leivseth G (2011)
    Psychosocial interventions as part of breast cancer rehabilitation programs? Results from a systematic review
    Psychooncology, 20 (9), 909-18
    PubMed 20821803
49. Fosså SD, Cvancarova M, Chen L, Allan AL, Oldenburg J, Peterson DR, Travis LB (2011)
    Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients
    J Clin Oncol, 29 (8), 963-70
    PubMed 21300926
50. Fosså SD, Hamre HM (2011)
    [Childhood cancer and fertility]
    Tidsskr Nor Laegeforen, 131 (15), 1412
    PubMed 21844933
51. Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, Carson WE, Chang AE, Characiejus D, Choudhury AR, Coukos G, de Gruijl T, Dillman RO, Dolstra H, Dranoff G, Durrant LG et al. (2011)
    Defining the critical hurdles in cancer immunotherapy
    J Transl Med, 9 (1), 214
    PubMed 22168571
52. Franco-Lie I, Iversen T, Robsahm TE, Abdelnoor M (2011)
    Incidence trends of melanoma of the skin compared with other localisations, in the Norwegian population, 1956-2005
    Ann Oncol, 22 (6), 1443-50
    PubMed 21135054
53. Førland DT, Johnson E, Saetre L, Lyberg T, Lygren I, Hetland G (2011)
    Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn's disease
    Scand J Immunol, 73 (1), 66-75
    PubMed 21129005
54. Gjerset GM, Fosså SD, Courneya KS, Skovlund E, Jacobsen AB, Thorsen L (2011)
    Interest and preferences for exercise counselling and programming among Norwegian cancer survivors
    Eur J Cancer Care (Engl), 20 (1), 96-105
    PubMed 20345456
55. Gjerset GM, Fosså SD, Courneya KS, Skovlund E, Thorsen L (2011)
    Exercise behavior in cancer survivors and associated factors
    J Cancer Surviv, 5 (1), 35-43
    PubMed 20890674
56. Gjerset GM, Fosså SD, Dahl AA, Loge JH, Ensby T, Thorsen L (2011)
    Effects of a 1-week inpatient course including information, physical activity, and group sessions for prostate cancer patients
    J Cancer Educ, 26 (4), 754-60
    PubMed 21626449
57. Graugaard PK, Rogg L, Eide H, Uhlig T, Loge JH (2011)
    Ways of providing the patient with a prognosis: a terminology of employed strategies based on qualitative data
    Patient Educ Couns, 83 (1), 80-6
    PubMed 20570463
58. Grinde MT, Moestue SA, Borgan E, Risa Ø, Engebraaten O, Gribbestad IS (2011)
    13C high-resolution-magic angle spinning MRS reveals differences in glucose metabolism between two breast cancer xenograft models with different gene expression patterns
    NMR Biomed, 24 (10), 1243-52
    PubMed 21462378
59. Grondahl P, Ikdahl SE, Dahl AA (2011)
    Forensic psychiatric screening reports - an update
    J. Forensic Psychiatry Psychol., 22 (2), 278-282
60. Grotmol T, Bray F, Holte H, Haugen M, Kunz L, Tretli S, Aalen OO, Moger TA (2011)
    Frailty modeling of the bimodal age-incidence of Hodgkin lymphoma in the Nordic countries
    Cancer Epidemiol Biomarkers Prev, 20 (7), 1350-7
    PubMed 21558495
61. Grov EK, Fosså SD, Dahl AA (2011)
    Insomnia in elderly cancer survivors--a population-based controlled study of associations with lifestyle, morbidity, and psychosocial factors. Results from the Health Survey of North-Trøndelag County (HUNT-2). Insomnia in elderly cancer survivors
    Support Care Cancer, 19 (9), 1319-26
    PubMed 20632038
62. Grov EK, Fosså SD, Dahl AA (2011)
    Morbidity, life style and psychosocial situation in cancer survivors aged 60-69 years: results from the Nord-Trøndelag health study (the HUNT-II study)
    BMC Cancer, 11, 34
    PubMed 21266091
63. Grov EK, Fosså SD, Dahl AA (2011)
    Short-term and long-term elderly cancer survivors: a population-based comparative and controlled study of morbidity, psychosocial situation, and lifestyle
    Eur J Oncol Nurs, 15 (3), 213-20
    PubMed 20674499
64. Gudbergsson SB, Fosså SD, Dahl AA (2011)
    Are there sex differences in the work ability of cancer survivors? Norwegian experiences from the NOCWO study
    Support Care Cancer, 19 (3), 323-31
    PubMed 20135150
65. Gudbergsson SB, Torp S, Fløtten T, Fosså SD, Nielsen R, Dahl AA (2011)
    A comparative study of cancer patients with short and long sick-leave after primary treatment
    Acta Oncol, 50 (3), 381-9
    PubMed 20843177
66. Hadzidimitriou A, Agathangelidis A, Darzentas N, Murray F, Delfau-Larue MH, Pedersen LB, Lopez AN, Dagklis A, Rombout P, Beldjord K, Kolstad A, Dreyling MH, Anagnostopoulos A, Tsaftaris A, Mavragani-Tsipidou P, Rosenwald A, Ponzoni M, Groenen P, Ghia P, Sander B, Papadaki T, Campo E, Geisler C, Rosenquist R, Davi F et al. (2011)
    Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
    Blood, 118 (11), 3088-95
    PubMed 21791422
67. Hagtvedt T, Aaløkken TM, Smith HJ, Graff BA, Holte H, Kolbenstvedt A (2011)
    Enhancement characteristics of lymphomatous lymph nodes of the mediastinum
    Acta Radiol, 52 (10), 1113-8
    PubMed 22052959
68. Hamfjord J, Stangeland AM, Skrede ML, Tveit KM, Ikdahl T, Kure EH (2011)
    Wobble-enhanced ARMS method for detection of KRAS and BRAF mutations
    Diagn Mol Pathol, 20 (3), 158-65
    PubMed 21817902
69. Hamid O, Schmidt H, Nissan A, Ridolfi L, Aamdal S, Hansson J, Guida M, Hyams DM, Gómez H, Bastholt L, Chasalow SD, Berman D (2011)
    A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
    J Transl Med, 9, 204
    PubMed 22123319
70. Hammerman PS, Sos ML, Ramos AH, Xu C, Dutt A, Zhou W, Brace LE, Woods BA, Lin W, Zhang J, Deng X, Lim SM, Heynck S, Peifer M, Simard JR, Lawrence MS, Onofrio RC, Salvesen HB, Seidel D, Zander T, Heuckmann JM, Soltermann A, Moch H, Koker M, Leenders F et al. (2011)
    Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer
    Cancer Discov, 1 (1), 78-89
    PubMed 22328973
71. Hansson J, Aamdal S, Bastholt L, Brandberg Y, Hernberg M, Nilsson B, Stierner U, von der Maase H, Nordic Melanoma Cooperative Group (2011)
    Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial
    Lancet Oncol, 12 (2), 144-52
    PubMed 21256809
72. Helbostad JL, Oldervoll LM, Fayers PM, Jordhøy MS, Fearon KC, Strasser F, Kaasa S (2011)
    Development of a computer-administered mobility questionnaire
    Support Care Cancer, 19 (6), 745-55
    PubMed 20336325
73. Helland Å, Anglesio MS, George J, Cowin PA, Johnstone CN, House CM, Sheppard KE, Etemadmoghadam D, Melnyk N, Rustgi AK, Phillips WA, Johnsen H, Holm R, Kristensen GB, Birrer MJ, Australian Ovarian Cancer Study Group, Pearson RB, Børresen-Dale AL, Huntsman DG, deFazio A, Creighton CJ, Smyth GK, Bowtell DD (2011)
    Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers
    PLoS One, 6 (4), e18064
    PubMed 21533284
74. Helland Å, Skaug HM, Kleinberg L, Iversen ML, Rud AK, Fleischer T, Sagerup C, Solberg S, Jørgensen L, Ariansen S, Brustugun OT (2011)
    EGFR gene alterations in a Norwegian cohort of lung cancer patients selected for surgery
    J Thorac Oncol, 6 (5), 947-50
    PubMed 21623266
75. Hellbom M, Bergelt C, Bergenmar M, Gijsen B, Loge JH, Rautalahti M, Smaradottir A, Johansen C (2011)
    Cancer rehabilitation: A Nordic and European perspective
    Acta Oncol, 50 (2), 179-86
    PubMed 21231779
76. Hess SL, Jóhannsdóttir IM, Hamre H, Kiserud CE, Loge JH, Fosså SD (2011)
    Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects
    Acta Oncol, 50 (5), 653-9
    PubMed 21261507
77. Hetland G, Johnson E, Lyberg T, Kvalheim G (2011)
    The Mushroom Agaricus blazei Murill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Th1/Th2 Imbalance and Inflammation
    Adv Pharmacol Sci, 2011, 157015
    PubMed 21912538
78. Heuser K, Cvancarova M, Gjerstad L, Taubøll E (2011)
    Is Temporal Lobe Epilepsy with childhood febrile seizures a distinctive entity? A comparative study
    Seizure, 20 (2), 163-6
    PubMed 21167748
79. Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, Fainsinger R, Aass N, Kaasa S, European Palliative Care Research Collaborative (EPCRC) (2011)
    Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review
    J Pain Symptom Manage, 41 (6), 1073-93
    PubMed 21621130
80. Hjortland GO, Meza-Zepeda LA, Beiske K, Ree AH, Tveito S, Hoifodt H, Bohler PJ, Hole KH, Myklebost O, Fodstad O, Smeland S, Hovig E (2011)
    Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma
    BMC Cancer, 11, 455
    PubMed 22014070
81. Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen J, Andersen L, Evensen JF, Overgaard J (2011)
    Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials
    Acta Oncol, 50 (7), 1006-14
    PubMed 21790306
82. Hurmuzlu M, Aarstad HJ, Aarstad AK, Hjermstad MJ, Viste A (2011)
    Health-related quality of life in long-term survivors after high-dose chemoradiotherapy followed by surgery in esophageal cancer
    Dis Esophagus, 24 (1), 39-47
    PubMed 20819100
83. Hysing J, Wist E (2011)
    Cardiotoxic effects of trastuzumab
    Tidsskr Nor Laegeforen, 131 (22), 2239-41
    PubMed 22085949
84. Haakensen VD, Bjøro T, Lüders T, Riis M, Bukholm IK, Kristensen VN, Troester MA, Homen MM, Ursin G, Børresen-Dale AL, Helland Å (2011)
    Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas
    BMC Cancer, 11, 332
    PubMed 21812955
85. Haakensen VD, Lingjaerde OC, Lüders T, Riis M, Prat A, Troester MA, Holmen MM, Frantzen JO, Romundstad L, Navjord D, Bukholm IK, Johannesen TB, Perou CM, Ursin G, Kristensen VN, Børresen-Dale AL, Helland A (2011)
    Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features
    BMC Med Genomics, 4, 77
    PubMed 22044755
86. Iversen A, Thune I, McTiernan A, Emaus A, Finstad SE, Flote V, Wilsgaard T, Lipson SF, Ellison PT, Jasienska G, Furberg AS (2011)
    Ovarian hormones and reproductive risk factors for breast cancer in premenopausal women: the Norwegian EBBA-I study
    Hum Reprod, 26 (6), 1519-29
    PubMed 21467202
87. Janni W, Vogl FD, Wiedswang G, Synnestvedt M, Fehm T, Jückstock J, Borgen E, Rack B, Braun S, Sommer H, Solomayer E, Pantel K, Nesland J, Friese K, Naume B (2011)
    Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis
    Clin Cancer Res, 17 (9), 2967-76
    PubMed 21415211
88. Jebsen NL, Bruland ØS, Eriksson M, Engellau J, Turesson I, Folin A, Trovik CS, Hall KS (2011)
    Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall
    Int J Radiat Oncol Biol Phys, 81 (5), 1359-66
    PubMed 20933339
89. Jóhannsdóttir IM, Moum T, Hjermstad MJ, Wesenberg F, Hjorth L, Schrøder H, Lähteenmäki PM, Jónmundsson G, Loge JH (2011)
    Emotional Functioning and School Contentment in Adolescent Survivors of Acute Myeloid Leukemia, Infratentorial Astrocytoma, and Wilms Tumor
    J Adolesc Young Adult Oncol, 1 (3), 133-139
    PubMed 23610734
90. Johansen S, Reinertsen KV, Knutstad K, Olsen DR, Fosså SD (2011)
    Dose distribution in the thyroid gland following radiation therapy of breast cancer--a retrospective study
    Radiat Oncol, 6, 68
    PubMed 21651829
91. Johnsen HE, Geisler C, Juvonen E, Remes K, Juliusson G, Hörnsten P, Kvaloy S, Kvalheim G, Jürgensen GW, Pedersen LM, Bergmann OJ, Schmitz A, Boegsted M (2011)
    Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment
    Bone Marrow Transplant, 46 (1), 44-51
    PubMed 20436517
92. Josefsen D, Forfang L, Dyrhaug M, Blystad AK, Stokke T, Smeland EB, Kvalheim G (2011)
    Side population cells in highly enriched CD34-positive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy
    Eur J Haematol, 87 (6), 494-502
    PubMed 21752097
93. Kamalakaran S, Varadan V, Giercksky Russnes HE, Levy D, Kendall J, Janevski A, Riggs M, Banerjee N, Synnestvedt M, Schlichting E, Kåresen R, Shama Prasada K, Rotti H, Rao R, Rao L, Eric Tang MH, Satyamoorthy K, Lucito R, Wigler M, Dimitrova N, Naume B, Borresen-Dale AL, Hicks JB (2011)
    DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables
    Mol Oncol, 5 (1), 77-92
    PubMed 21169070
94. Kjærgaard T, Cvancarova M, Steinsvåg SK (2011)
    Cigarette smoking and self-assessed upper airway health
    Eur Arch Otorhinolaryngol, 268 (2), 219-26
    PubMed 20512499
95. Klepstad P, Fladvad T, Skorpen F, Bjordal K, Caraceni A, Dale O, Davies A, Kloke M, Lundström S, Maltoni M, Radbruch L, Sabatowski R, Sigurdardottir V, Strasser F, Fayers PM, Kaasa S, European Palliative Care Research Collaborative (EPCRC), European Association for Palliative Care Research Network (2011)
    Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients
    Pain, 152 (5), 1139-45
    PubMed 21398039
96. Knappskog S, Bjørnslett M, Myklebust LM, Huijts PE, Vreeswijk MP, Edvardsen H, Guo Y, Zhang X, Yang M, Ylisaukko-Oja SK, Alhopuro P, Arola J, Tollenaar RA, van Asperen CJ, Seynaeve C, Staalesen V, Chrisanthar R, Løkkevik E, Salvesen HB, Evans DG, Newman WG, Lin D, Aaltonen LA, Børresen-Dale AL, Tell GS et al. (2011)
    The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians
    Cancer Cell, 19 (2), 273-82
    PubMed 21316605
97. Knudsen AK, Brunelli C, Kaasa S, Apolone G, Corli O, Montanari M, Fainsinger R, Aass N, Fayers P, Caraceni A, Klepstad P, European Palliative Care Research Collaborative, European Pharmacogenetic Study (2011)
    Which variables are associated with pain intensity and treatment response in advanced cancer patients?--Implications for a future classification system for cancer pain
    Eur J Pain, 15 (3), 320-7
    PubMed 20822941
98. Knudtsen IS, Rødal J, Brustugun OT, Helland Å, Skretting A, Malinen E (2011)
    Dynamic respiratory gated (18)FDG-PET of lung tumors - a feasibility study
    Acta Oncol, 50 (6), 889-96
    PubMed 21767189
99. Kristiansen W, Haugen TB, Witczak O, Andersen JM, Fosså SD, Aschim EL (2011)
    CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility
    Int J Androl, 34 (1), 77-83
    PubMed 20345875
100. Kurita GP, Sjogren P, Ekholm O, Kaasa S, Loge JH, Klepstad P (2011)
     Effects of Low-Dose Opioids on Cognitive Dysfunction Reply
     J. Clin. Oncol., 29 (32), 4343-4344
101. Kurita GP, Sjøgren P, Ekholm O, Kaasa S, Loge JH, Poviloniene I, Klepstad P (2011)
     Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study
     J Clin Oncol, 29 (10), 1297-303
     PubMed 21357785
102. Kyriazoglou AI, Dimitriadis E, Arnogiannaki N, Brandal P, Heim S, Pandis N (2011)
     Similar cytogenetic findings in two synchronous secondary peripheral chondrosarcomas in a patient with multiple osteochondromas
     Cancer Genet, 204 (12), 677-81
     PubMed 22285020
103. Kyte JA, Gaudernack G, Dueland S, Trachsel S, Julsrud L, Aamdal S (2011)
     Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients
     Clin Cancer Res, 17 (13), 4568-80
     PubMed 21586625
104. Landmark-Høyvik H, Dumeaux V, Reinertsen KV, Edvardsen H, Fosså SD, Børresen-Dale AL (2011)
     Blood gene expression profiling of breast cancer survivors experiencing fibrosis
     Int J Radiat Oncol Biol Phys, 79 (3), 875-83
     PubMed 21129856
105. Larssen L, Medhus AW, Hjermstad MJ, Körner H, Glomsaker T, Søberg T, Gleditsch D, Hovde O, Nesbakken A, Tholfsen JK, Skreden K, Hauge T (2011)
     Patient-reported outcomes in palliative gastrointestinal stenting: a Norwegian multicenter study
     Surg Endosc, 25 (10), 3162-9
     PubMed 21487867
106. Lindbohm ML, Kuosma E, Taskila T, Hietanen P, Carlsen K, Gudbergsson S, Gunnarsdottir H (2011)
     Cancer as the cause of changes in work situation (a NOCWO study)
     Psychooncology, 20 (8), 805-12
     PubMed 20623820
107. Lægreid IK, Aasarød K, Jordhøy M (2011)
     End-stage renal disease and recruitment to randomized trials: why is it so difficult? Results from a survey among Norwegian nephrologists
     Scand J Urol Nephrol, 45 (4), 285-9
     PubMed 21492050
108. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Stokke T, Nesland JM, Suo Z (2011)
     Prostate cancer cell lines under hypoxia exhibit greater stem-like properties
     PLoS One, 6 (12), e29170
     PubMed 22216200
109. Marcos NT, Bennett EP, Gomes J, Magalhaes A, Gomes C, David L, Dar I, Jeanneau C, DeFrees S, Krustrup D, Vogel LK, Kure EH, Burchell J, Taylor-Papadimitriou J, Clausen H, Mandel U, Reis CA (2011)
     ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues
     Front Biosci (Elite Ed), 3, 1443-55
     PubMed 21622148
110. Mead GM, Fossa SD, Oliver RT, Joffe JK, Huddart RA, Roberts JT, Pollock P, Gabe R, Stenning SP, MRC/EORTC seminoma trial collaborators (2011)
     Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up
     J Natl Cancer Inst, 103 (3), 241-9
     PubMed 21212385
111. Mikalsen LT, Dhakal HP, Bruland OS, Nesland JM, Olsen DR (2011)
     Quantification of angiogenesis in breast cancer by automated vessel identification in CD34 immunohistochemical sections
     Anticancer Res, 31 (12), 4053-60
     PubMed 22199261
112. Moestue SA, Engebraaten O, Gribbestad IS (2011)
     Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy
     Mol Oncol, 5 (3), 224-41
     PubMed 21536506
113. Mohty M, Duarte RF, Croockewit S, Hübel K, Kvalheim G, Russell N (2011)
     The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation
     Leukemia, 25 (1), 1-6
     PubMed 21224858
114. Molloy TJ, Bosma AJ, Baumbusch LO, Synnestvedt M, Borgen E, Russnes HG, Schlichting E, van't Veer LJ, Naume B (2011)
     The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients
     Breast Cancer Res, 13 (3), R61
     PubMed 21672237
115. Myklebust MP, Bruland O, Fluge Ø, Skarstein A, Balteskard L, Dahl O (2011)
     MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer
     Br J Cancer, 105 (11), 1719-25
     PubMed 22045185
116. Müller KM, Tveteraas IH, Aasrum M, Ødegård J, Dawood M, Dajani O, Christoffersen T, Sandnes DL (2011)
     Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells
     BMC Cancer, 11, 421
     PubMed 21961726
117. Negaard HF, Sandset PM, Kolset SO, Svennevig K, Østenstad B, Iversen PO (2011)
     Associations between regulators of extracellular matrix and hemostatic factors in hematologic neoplasias
     Leuk Lymphoma, 52 (6), 1157-9
     PubMed 21463121
118. Nesvold IL, Reinertsen KV, Fosså SD, Dahl AA (2011)
     The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study
     J Cancer Surviv, 5 (1), 62-72
     PubMed 20972640
119. Norum J, Olsen A, Småstuen M, Nieder C, Broderstad AR (2011)
     Health consumption in Sami-speaking municipalities with regard to cancer and radiotherapy
     Int J Circumpolar Health, 70 (3), 319-28
     PubMed 21703126
120. Ohnstad HO, Paulsen EB, Noordhuis P, Berg M, Lothe RA, Vassilev LT, Myklebost O (2011)
     MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines
     BMC Cancer, 11, 211:1-11
     PubMed 21624110
121. Oldenburg J, Lorch A, Fosså SD (2011)
     Late relapse of germ cell tumors
     Hematol Oncol Clin North Am, 25 (3), 615-26, x
     PubMed 21570613
122. Oldervoll LM, Loge JH, Lydersen S, Paltiel H, Asp MB, Nygaard UV, Oredalen E, Frantzen TL, Lesteberg I, Amundsen L, Hjermstad MJ, Haugen DF, Paulsen Ø, Kaasa S (2011)
     Physical exercise for cancer patients with advanced disease: a randomized controlled trial
     Oncologist, 16 (11), 1649-57
     PubMed 21948693
123. Oliver RT, Mead GM, Rustin GJ, Joffe JK, Aass N, Coleman R, Gabe R, Pollock P, Stenning SP (2011)
     Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214)
     J Clin Oncol, 29 (8), 957-62
     PubMed 21282539
124. Olofsson SE, Tandstad T, Jerkeman M, Dahl O, Ståhl O, Klepp O, Bremnes RM, Cohn-Cedermark G, Langberg CW, Laurell A, Solberg A, Stierner U, Wahlqvist R, Wijkström H, Anderson H, Cavallin-Ståhl E (2011)
     Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group
     J Clin Oncol, 29 (15), 2032-9
     PubMed 21482994
125. Olssøn I, Sørebø Ø, Dahl AA (2011)
     A cross-sectional testing of The Iowa Personality Disorder Screen in a psychiatric outpatient setting
     BMC Psychiatry, 11, 105
     PubMed 21711506
126. Orre IJ, Reinertsen KV, Aukrust P, Dahl AA, Fosså SD, Ueland T, Murison R (2011)
     Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors
     J Psychosom Res, 71 (3), 136-41
     PubMed 21843747
127. Pfreundschuh M, Kuhnt E, Trümper L, Osterborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani PL, Shpilberg O, Kvaloy S, de Nully Brown P, Stahel R, Milpied N, López-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N, MabThera International Trial (MInT) Group (2011)
     CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
     Lancet Oncol, 12 (11), 1013-22
     PubMed 21940214
128. Reinertsen KV, Grenaker Alnæs GI, Landmark-Høyvik H, Loge JH, Wist E, Kristensen VN, Fosså SD, Edvardsen H (2011)
     Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway
     Brain Behav Immun, 25 (7), 1376-83
     PubMed 21496483
129. Revheim ME, Hole KH, Bruland OS, Haugland HK, Hall KS, Seierstad T (2011)
     DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour
     Acta Oncol, 50 (1), 148-50
     PubMed 21110775
130. Revheim ME, Røe K, Bruland ØS, Bach-Gansmo T, Skretting A, Seierstad T (2011)
     Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT
     Mol Imaging Biol, 13 (6), 1234-40
     PubMed 21161686
131. Revheim ME, Winge-Main AK, Hagen G, Fjeld JG, Fosså SD, Lilleby W (2011)
     Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma
     Clin Oncol (R Coll Radiol), 23 (5), 339-43
     PubMed 21134733
132. Ringdal GI, Ringdal K, Juliebø V, Wyller TB, Hjermstad MJ, Loge JH (2011)
     Using the Mini-Mental State Examination to screen for delirium in elderly patients with hip fracture
     Dement Geriatr Cogn Disord, 32 (6), 394-400
     PubMed 22301509
133. Rønneberg JA, Fleischer T, Solvang HK, Nordgard SH, Edvardsen H, Potapenko I, Nebdal D, Daviaud C, Gut I, Bukholm I, Naume B, Børresen-Dale AL, Tost J, Kristensen V (2011)
     Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer
     Mol Oncol, 5 (1), 61-76
     PubMed 21212030
134. Sartor O, Bruland O (2011)
     Stromal targeted therapies in prostate and renal cancer: new concepts and knowledge
     Clin Genitourin Cancer, 9 (1), 1-2
     PubMed 21925102
135. Sartor O, Goeckeler W, Bruland O (2011)
     Stromal targeted therapy in bone metastatic prostate cancer: promise delivered
     Asian J Androl, 13 (6), 783-4
     PubMed 21857688
136. Scheie D, Meling TR, Cvancarova M, Skullerud K, Mørk S, Lote K, Eide TJ, Helseth E, Beiske K (2011)
     Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases
     Neuro Oncol, 13 (11), 1225-33
     PubMed 21856683
137. Skjelbred CF, Svendsen M, Haugan V, Eek AK, Clausen KO, Kure EH, Tuimala JT, Svendsen MV, Norppa H, Hansteen IL (2011)
     Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes
     Carcinogenesis, 32 (3), 399-405
     PubMed 21097530
138. Skaali T, Fosså SD, Andersson S, Cvancarova M, Langberg CW, Lehne G, Dahl AA (2011)
     A prospective study of neuropsychological functioning in testicular cancer patients
     Ann Oncol, 22 (5), 1062-70
     PubMed 21048038
139. Skaali T, Fosså SD, Andersson S, Cvancarova M, Langberg CW, Lehne G, Dahl AA (2011)
     Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress
     J Psychosom Res, 70 (5), 403-10
     PubMed 21511070
140. Skaali T, Fosså SD, Andersson S, Langberg CW, Lehne G, Dahl AA (2011)
     Is psychological distress in men recently diagnosed with testicular cancer associated with their neuropsychological test performance?
     Psychooncology, 20 (4), 369-77
     PubMed 20878832
141. Skaali T, Fosså SD, Dahl AA (2011)
     A prospective study of cognitive complaints in patients with testicular cancer
     Clin Genitourin Cancer, 9 (1), 6-13
     PubMed 21729683
142. Smeland S, Bruland OS, Hjorth L, Brosjö O, Bjerkehagen B, Osterlundh G, Jakobson A, Hall KS, Monge OR, Björk O, Alvegaard TA (2011)
     Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years
     Acta Orthop, 82 (2), 211-6
     PubMed 21434784
143. Stafseth SK, Solms D, Bredal IS (2011)
     The characterisation of workloads and nursing staff allocation in intensive care units: a descriptive study using the Nursing Activities Score for the first time in Norway
     Intensive Crit Care Nurs, 27 (5), 290-4
     PubMed 21871805
144. Stakkestad Ø, Larsen AC, Kvissel AK, Eikvar S, Ørstavik S, Skålhegg BS (2011)
     Protein kinase A type I activates a CRE-element more efficiently than protein kinase A type II regardless of C subunit isoform
     BMC Biochem, 12, 7
     PubMed 21303506
145. Steindal SA, Bredal IS, Sørbye LW, Lerdal A (2011)
     Pain control at the end of life: a comparative study of hospitalized cancer and noncancer patients
     Scand J Caring Sci, 25 (4), 771-9
     PubMed 21564152
146. Stensheim H, Cvancarova M, Møller B, Fosså SD (2011)
     Pregnancy after adolescent and adult cancer: a population-based matched cohort study
     Int J Cancer, 129 (5), 1225-36
     PubMed 21387311
147. Stensvold A, Dahl AA, Fosså SD, Axcrona K, Lilleby W, Brennhovd B, Smeland S (2011)
     Clinicians' use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center
     Acta Oncol, 50 (3), 408-14
     PubMed 20586661
148. Stensvold E, Magelssen H, Oskam IC (2011)
     Fertility-preserving measures for girls and young women with cancer
     Tidsskr Nor Laegeforen, 131 (15), 1429-32
     PubMed 21844944
149. Stensvold E, Magelssen H, Oskam IC (2011)
     Fertility-preserving measures for boys and young men with cancer
     Tidsskr Nor Laegeforen, 131 (15), 1433-5
     PubMed 21844945
150. Stephenson AJ, Aprikian AG, Gilligan TD, Oldenburg J, Powles T, Toner GC, Waters WB (2011)
     Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009
     Urology, 78 (4 Suppl), S444-55
     PubMed 21986224
151. Strand TE, Brunsvig PF, Johannessen DC, Sundstrøm S, Wang M, Hornslien K, Bremnes RM, Stensvold A, Garpestad O, Norstein J (2011)
     Potentially curative radiotherapy for non-small-cell lung cancer in Norway: a population-based study of survival
     Int J Radiat Oncol Biol Phys, 80 (1), 133-41
     PubMed 20452137
152. Suhrke P, Mæhlen J, Schlichting E, Jørgensen KJ, Gøtzsche PC, Zahl PH (2011)
     Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data
     BMJ, 343, d4692
     PubMed 21914765
153. Suso EM, Dueland S, Rasmussen AM, Vetrhus T, Aamdal S, Kvalheim G, Gaudernack G (2011)
     hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
     Cancer Immunol Immunother, 60 (6), 809-18
     PubMed 21365467
154. Tamburstuen MV, Reseland JE, Spahr A, Brookes SJ, Kvalheim G, Slaby I, Snead ML, Lyngstadaas SP (2011)
     Ameloblastin expression and putative autoregulation in mesenchymal cells suggest a role in early bone formation and repair
     Bone, 48 (2), 406-13
     PubMed 20854943
155. Tandstad T, Smaaland R, Solberg A, Bremnes RM, Langberg CW, Laurell A, Stierner UK, Ståhl O, Cavallin-Ståhl EK, Klepp OH, Dahl O, Cohn-Cedermark G (2011)
     Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group
     J Clin Oncol, 29 (6), 719-25
     PubMed 21205748
156. Tangeraas T, Midtvedt K, Cvancarova M, Hirth A, Fredriksen PM, Tonstad S, Isaksen GA, Bjerre A (2011)
     Cardiorespiratory fitness in young adults with a history of renal transplantation in childhood
     Pediatr Nephrol, 26 (11), 2041-9
     PubMed 21541798
157. Thorsen L, Gjerset GM, Loge JH, Kiserud CE, Skovlund E, Fløtten T, Fosså SD (2011)
     Cancer patients' needs for rehabilitation services
     Acta Oncol, 50 (2), 212-22
     PubMed 21231783
158. Torfoss D, Sandstad B, Mollnes TE, Høiby EA, Holte H, Bjerner J, Bjøro T, Gaudernack G, Kvalheim G, Kvaløy S (2011)
     The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily
     Scand J Immunol, 74 (6), 632-9
     PubMed 21883353
159. Torp S, Gudbergsson SB, Dahl AA, Fosså SD, Fløtten T (2011)
     Social support at work and work changes among cancer survivors in Norway
     Scand J Public Health, 39 (6 Suppl), 33-42
     PubMed 21382846
160. Tsai HR, Gjesdal O, Wethal T, Haugaa KH, Fosså A, Fosså SD, Edvardsen T (2011)
     Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy
     Am J Cardiol, 107 (3), 472-7
     PubMed 21257017
161. Turzer M, Brustugun OT, Waldeland E, Helland A (2011)
     Stereotactic body radiation therapy is effective and safe in patients with early-stage non-small cell lung cancer with low performance status and severe comorbidity
     Case Rep Oncol, 4 (1), 25-34
     PubMed 21526003
162. Tveito S, Andersen K, Kåresen R, Fodstad Ø (2011)
     Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles
     Breast Cancer Res, 13 (4), R75
     PubMed 21816090
163. Tøien K, Bredal IS, Skogstad L, Myhren H, Ekeberg O (2011)
     Health related quality of life in trauma patients. Data from a one-year follow up study compared with the general population
     Scand J Trauma Resusc Emerg Med, 19, 22
     PubMed 21477280
164. Vistad I, Cvancarova M, Kristensen GB, Fosså SD (2011)
     A study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer
     J Cancer Surviv, 5 (2), 208-16
     PubMed 21259075
165. Vollan HK, Caldas C (2011)
     The breast cancer genome--a key for better oncology
     BMC Cancer, 11, 501
     PubMed 22128823
166. Wahlin BE, Sundström C, Holte H, Hagberg H, Erlanson M, Nilsson-Ehle H, Lindén O, Nordström M, Ostenstad B, Geisler CH, Brown Pde N, Lehtinen T, Maisenhölder M, Tierens AM, Sander B, Christensson B, Kimby E (2011)
     T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab
     Clin Cancer Res, 17 (12), 4136-44
     PubMed 21518780
167. Warde P, Huddart R, Bolton D, Heidenreich A, Gilligan T, Fossa S (2011)
     Management of localized seminoma, stage I-II: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009
     Urology, 78 (4 Suppl), S435-43
     PubMed 21986223
168. Weisenburger DD, Savage KJ, Harris NL, Gascoyne RD, Jaffe ES, MacLennan KA, Rüdiger T, Pileri S, Nakamura S, Nathwani B, Campo E, Berger F, Coiffier B, Kim WS, Holte H, Federico M, Au WY, Tobinai K, Armitage JO, Vose JM, International Peripheral T-cell Lymphoma Project (2011)
     Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
     Blood, 117 (12), 3402-8
     PubMed 21270441
169. Wiig JN, Larsen SG, Dueland S, Flatmark K, Giercksky KE (2011)
     Salvage surgery for locally recurrent rectal cancer: total mesorectal excision during the primary operation does not influence the outcome
     Colorectal Dis, 13 (5), 506-11
     PubMed 20236148
170. Yri OE, Torfoss D, Hungnes O, Tierens A, Waalen K, Nordøy T, Dudman S, Kilander A, Wader KF, Ostenstad B, Ekanger R, Meyer P, Kolstad A (2011)
     Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment
     Blood, 118 (26), 6769-71
     PubMed 22058114
171. Zaikova O, Fosså SD, Bruland OS, Giercksky KE, Sandstad B, Skjeldal S (2011)
     Radiotherapy or surgery for spine metastases?
     Acta Orthop, 82 (3), 365-71
     PubMed 21434789
172. Zhao X, Rødland EA, Sørlie T, Naume B, Langerød A, Frigessi A, Kristensen VN, Børresen-Dale AL, Lingjærde OC (2011)
     Combining gene signatures improves prediction of breast cancer survival
     PLoS One, 6 (3), e17845
     PubMed 21423775
173. Zinöcker S, Wang MY, Gaustad P, Kvalheim G, Rolstad B, Vaage JT (2011)
     Mycoplasma contamination revisited: mesenchymal stromal cells harboring Mycoplasma hyorhinis potently inhibit lymphocyte proliferation in vitro
     PLoS One, 6 (1), e16005
     PubMed 21264307
174. Zwierzina H, Bergmann L, Fiebig H, Aamdal S, Schöffski P, Witthohn K, Lentzen H (2011)
     The preclinical and clinical activity of aviscumine: a potential anticancer drug
     Eur J Cancer, 47 (10), 1450-7
     PubMed 21482461
175. Aamdal S (2011)
     Current approaches to adjuvant therapy of melanoma
     Eur J Cancer, 47 Suppl 3, S336-7
     PubMed 21944005